Abstract
Lianhua Qingwen capsule is a famous traditional Chinese medicine (TCM) prescription that is widely used for the treatment of respiratory diseases in China. To facilitate in-depth and global characterization of the chemical constituents of Lianhua Qingwen capsule, a profiling method based on ultra-high performance liquid chromatography coupled with Fourier transform ion cyclotron resonance mass spectrometry (UHPLC-FT-ICR-MS) was applied in both positive and negative ion modes for the comprehensive characterization of the chemical profiles of Lianhua Qingwen capsule. A total of 596 compounds were identified or tentatively characterized, including 137 flavonoids, 46 phenylpropanoids, 43 phenylethanoid glycosides, 145 terpenoids, 83 organic acids and their derivatives, 15 quinones, 39 alkaloids, 32 alcohol glycosides and 56 other compounds. Thus, this results widely extended and enriched the chemical constituents of Lianhua Qingwen capsule, which will provide comprehensive and valuable information for its quality control and further pharmacological study, facilitate understanding the effective substance and pharmacodynamic material basis, thereby providing a solid foundation for further development of the Lianhuaqingwen capsule.
Keywords: Lianhua Qingwen capsule, UHPLC-FT-ICR-MS, Chemical constituents
Highlights
-
•
An UHPLC-FT-ICR-MS method was applied for the characterization of chemical constituents in Lianhuaqingwen capsule.
-
•
A total of 596 chemical constituents were characterized.
-
•
The study enriched the chemical constituents and provided a solid foundation for further development of the Lianhuaqingwen capsule.
1. Introduction
Lianhua Qingwen capsule is based on two traditional Chinese medicine prescriptions (TCMPs) named Maxingshigan decoction (as recorded in ShangHanLun in the Han Dynasty) and Yinqiao powder (as recorded in WenBingTiaoBian in the Qing Dynasty) of Chinese history, respectively [1]. Lianhua Qingwen capsule is composed of 13 herbal medicines [1]: Forsythiae Fructus (Lianqiao), Lonicerae Japonicae Flos (Jinyinhua), Ephedrae Herba Praeparata Cum Melle (Zhimahuang), Armeniacae Semen Amarum Tostum (Chaokuxingren), Gypsum Fibrosum (Shigao), Isatidis Radix (Banlangen), Dryopteridis Crassirhizomatis Rhizoma (Mianmaguanzhong), Houttuyniae Herba (Yuxingcao), Pogostemonis Herba (Guanghuoxiang), Rhei Radix et Rhizoma (Dahuang), Rhodiolae Crenulatae Radix et Rhizoma (Hongjingtian), Menthol (Bohenao), and Glycyrrhizae Radix et Rhizoma (Gancao). Lianhuaqingwen capsule possesses the functions of clearing away heat and detoxifying the lungs, and it can also be applied clinically to treat patients presenting with the symptoms of fever and respiratory diseases. Lianhua Qingwen capsule possesses anti-inflammatory [2] and anti-influenza activities against IBV [2] , H7N9 [3], H1N1 [4], and SARS-CoV-2 [5], which is widely used for the treatment of COVID-19 [[6], [7], [8], [9]]. Owing to its increasing success in the prevention and treatment of respiratory diseases, considerable attention has been paid worldwide to the Lianhua Qingwen capsule.
Traditional Chinese medicine (TCM) plays a non-negligible role in the prevention and treatment of diseases. The TCM formula has received more attention from researchers due to its remarkable therapeutic effectiveness in recent times. The TCM formula is composed of different herbal medicines with complex chemical compositions and presents synergistic effects via multi-components and multi-target mechanism. Therefore, it has become crucial to comprehensively characterize its chemical profile so as to elucidate the effective material basis. According to past reports on the analysis of the Lianhua Qingwen capsule, 61 compounds [10], 104 compounds [11] and 185 compounds [12] were unambiguously or tentatively identified, respectively. As a complicated prescription consisting of 13 herbal medicines, the actual chemical constituents of the Lianhua Qingwen capsule remain to be elucidated, albeit the inherent variety of compounds presents significant challenges in terms of separation and detection techniques for the rapid characterization of the chemical constituents. Thus, a rapid, sensitive, and accurate analytical method is necessary and urgent for the comprehensive chemical composition characterization of the Lianhua Qingwen capsule.
Modern analytical techniques have been applied to investigate the chemical constituents of TCM prescriptions. Ultra-high performance liquid chromatography-high-resolution mass spectrometry (UHPLC-HRMS) stands out from the other techniques in terms of the analysis of chemical components in TCM, due to the advantages of separation time, sensitivity, mass accuracy, resolution, and abundant information. To date, Fourier-transformed ion cyclotron resonance mass spectrometry (FT-ICR-MS) with a high resolution and unsurpassed mass measurement accuracy is a powerful and representative instrument in the mass spectrum fields [[13], [14], [15], [16], [17]]. UHPLC combined with FT-ICR-MS (UHPLC-FT-ICR-MS) is a powerful analytical technique for detecting and tentatively characterizing multi-components owing to its rapid elution, high sensitivity, high mass accuracy, high resolution, and abundance information [[18], [19], [20], [21]].
In the present study, a method based on UHPLC-FT-ICR-MS/MS was applied for the rapid, sensitive, and accurate characterization of various chemical components of the Lianhua Qingwen capsule. A total of 596 compounds were identified or tentatively characterized. Results of this investigation were expected to improve the quality control, promote the pharmacological study and expand the clinical applications of the Lianhua Qingwen capsule.
2. Materials and methods
2.1. Chemicals and reagents
Lianhua Qingwen capsule (Lot No. B2008172) were obtained from Yiling Pharmaceutical Co., Ltd. (Shijiazhuang, China). Reference compounds (purity>98 %) of chlorogenic acid, esculetin, caffeic acid, luteolin, apigenin, liquiritigenin, isoliquiritigenin, liquiritin, isoliquiritin, glycyrrhizic acid and glycyrrhetinic acid were purchased from Chengdu Must Bio-Technology Co., Ltd (Chengdu, China). Acetonitrile and formic acid of HPLC grade were obtained from Fisher Scientific (Fair Lawn, NJ, USA). Purified water was provided from Hangzhou Wahaha Corporation (Hangzhou, China).
2.2. Sample preparation
0.35 g of Lianhua Qingwen capsule was accurately measured, then respectively added into 7 mL water and methanol with ultrasonic treatment for 0.5 h, the water and methanol extract of Lianhua Qingwen capsule was prepared by diluting to a final concentration of 0.05 g/mL, subsequently the water and methanol extract of Lianhua Qingwen capsule were filtered through a 0.22 μm filter membrane for further analysis.
The standard stock solutions were prepared by dissolving chlorogenic acid, esculetin, caffeic acid, luteolin, apigenin, liquiritigenin, isoliquiritigenin, liquiritin, isoliquiritin, glycyrrhizic acid and glycyrrhetinic acid in methanol, respectively. And then the proper amount of stock solution of each reference substance was taken, mixed and finally diluted to an appropriate concentration which was stored at 4 °C for the following analysis.
2.3. Instruments and analytical conditions
Liquid chromatography analysis was carried out on an Agilent 1260 UPLC system (Agilent, USA). An ACQUITY UPLC HSS T3 column (2.1 mm × 100 mm, 1.8 μm, Waters, Ireland) being protected by an ACQUITY UPLC HSS T3 VanGuard Pre-Column (2.1 mm × 5 mm, 1.8 μm, Waters, Ireland) was utilized at 35 °C. The mobile phase system was composed of 0.1% formic acid in water (A) and acetonitrile (B). The gradient condition of the mobile phase was as following: 8% to 20%B (0–2 min); 20% to 50%B (2–20 min); 50% to 98%B (20–26 min); an isocratic elution of B (26–33 min), at a flow rate of 0.30 mL/min. The injection volume was 10 μL.
The UHPLC-FT-ICR-MS/MS detection was carried out on a Bruker Solarix 7.0T FT-ICR mass pectrometer coupled with an ESI interface. The ESI source was operated in positive-ionization and negative-ionization mode. The capillary voltage is set at 4.5 kV, the endplate offset is set at 500 V, dry gas flow is set at 8 L/min, dry gas temperature is set at 200 °C, nebulizer gas pressure is set at 4 bar. The collision gas and nebulizing gas were high-purity argon (Ar) and high-purity nitrogen (N2), respectively. Full-scan analysis was scanned from a mass range of m/z 100–1200. And the collision energy was initially set at 5 eV and then modified to obtain the representative fragment ions. Bruker Compass Hystar (version 4.1, Bruker Daltonics, Germany) and Fourier Transform Mass Spectrometer Control (version 2.1, Bruker Daltonics, Germany) were used for instrument control and data acquisition. Data Analysis Software (version 4.4; Bruker Daltonics, Germany) was used for data analysis.
3. Results and discussion
3.1. Chemical profiling of Lianhua Qingwen capsule
The representative base peak intensity chromatograms in positive and negative modes of Lianhua Qingwen capsule water and methanol extract were shown in Fig. 1, Fig. 2. The difference between water extract and methanol extract is mainly in the contents of compounds. Water and methanol extract of Lianhua Qingwen capsule were both used to get comprehensive information of chemical compounds in Lianhua Qingwen capsule. In total, 596 chemical constituents, including 137 flavonoids, 46 phenylpropanoids, 43 phenylethanoid glycosides, 145 terpenoids, 83 organic acids and their derivatives, 15 quinones, 39 alkaloids, 32 alcohol glycosides and 56 other phytochemicals, were unambiguously identified or tentatively characterized in Lianhua Qingwen capsule by UHPLC-FT-ICR-MS method. Among them, chlorogenic acid, esculetin, caffeic acid, luteolin, apigenin, liquiritigenin, isoliquiritigenin, liquiritin, isoliquiritin, glycyrrhizic acid and glycyrrhetinic acid were unambiguously identified based on data comparing with the reference compounds. Besides, the chemical constituents were tentatively characterized based on retention time, accurate molecular mass and MS2 data [[11], [12], [13],[18], [19], [20], [21], [22], [23], [24], [25], [26], [27], [28], [29], [30]]. The retention time, accurate mass weights of the precursor negative and positive ions, predicted molecular formula, mass error and fragment ions are summarized in Table 1. The chemical structures of major constituents are shown in Fig. S1.
Fig. 1.
UHPLC-FT-ICR-MS base peak intensity chromatograms in positive (A) and negative (B) modes of Lianhua Qingwen capsule water extract.
Fig. 2.
UHPLC-FT-ICR-MS base peak intensity chromatograms in positive (A) and negative (B) modes of Lianhua Qingwen capsule methanol extract.
Table 1.
Compounds identified in Lianhua Qingwen capsule by UHPLC-FT-ICR MS.
| No. | RT (min) | Identification | [M+H]+ |
[M − H]- |
Formula | Product ion m/z | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Observed | Calculated | Error (ppm) | Observed | Calculated | Error (ppm) | |||||
| 1 | 0.90 | Arginine | 175.11845 | 175.11895 | 2.86 | – | – | – | C6H14N4O2 | (+): 158 |
| 2 | 0.97 | Quinic acid | – | – | – | 191.05594 | 191.05611 | 0.91 | C7H12O6 | (−): 173, 127 |
| 3 | 1.14 | Cytidine | 244.09304 | 244.09280 | −1.01 | – | – | – | C9H13N3O5 | (+): 112 |
| 4 | 1.21 | Heterodendrin | 262.12879 | 262.12851 | −1.07 | – | – | – | C11H19NO6 | (+): 216, 178, 157 |
| 5 | 1.36 | Uridine | – | – | – | 243.06208 | 243.06226 | 0.74 | C9H12N2O6 | (−): 110 |
| 6 | 1.39 | Adenosine | 268.10448 | 268.10403 | −1.69 | – | – | – | C10H13N5O4 | (+): 136 |
| 7 | 1.40 | Guanosine | 284.09945 | 284.09894 | −1.78 | 282.08422 | 282.08439 | 0.63 | C10H13N5O5 | (+): 152 |
| 8 | 1.46 | Cornoside | 317.12390 | 317.12309 | −2.55 | 315.10845 | 315.10854 | 0.29 | C14H20O8 | (−): 153 |
| 9 | 1.48 | Succinic acid | – | – | – | 117.01922 | 117.01933 | 1.00 | C4H6O4 | – |
| 10 | 1.48 | Gallic acid-4-O-β-D-glucoside | – | – | – | 331.06709 | 331.06707 | −0.05 | C13H16O10 | (−): 169 |
| 11 | 1.55 | Rengyoside B | 321.15544 | 321.15439 | −3.26 | 319.13978 | 319.13984 | 0.20 | C14H24O8 | (−): 157, 139 |
| 12 | 1.61 | Rengynic acid-1′-O-β-D-glucoside | – | – | – | 335.13456 | 335.13476 | 0.59 | C14H24O9 | (−): 173 |
| 13 | 1.64 | Norephedrine-rhamnose-glucose | 460.21913 | 460.21772 | −3.05 | – | – | – | C21H33NO10 | (+): 298 |
| 14 | 1.72 | Ephedrine-rhamnose-glucose | 474.23490 | 474.23337 | −3.22 | – | – | – | C22H35NO10 | (+): 312, 166 |
| 15 | 1.78 | Gallic acid | – | – | – | 169.01406 | 169.01425 | 1.11 | C7H6O5 | (−): 125 |
| 16 | 1.80 | Citraconic acid | – | – | – | 129.01917 | 129.01933 | 1.27 | C5H6O4 | – |
| 17 | 1.89 | Caffeoylshikimic acid | 337.09074 | 337.09179 | 3.13 | 335.07705 | 335.07724 | 0.56 | C16H16O8 | (−): 179, 135 |
| 18 | 1.90 | Vanillic acid | – | – | – | 167.03481 | 167.03498 | 1.05 | C8H8O4 | (−): 152, 123 |
| 19 | 1.95 | Gallic acid-3-O-β-D-glucoside | – | – | – | 331.06699 | 331.06707 | 0.23 | C13H16O10 | (−): 169 |
| 20 | 1.96 | Phenylalanine hexose | 328.13953 | 328.13908 | −1.39 | 326.12446 | 326.12453 | 0.19 | C15H21NO7 | (−): 164 |
| 21 | 2.00 | Hydroxytyrosol glucoside | 317.12384 | 317.12309 | −2.35 | 315.10841 | 315.10854 | 0.41 | C14H20O8 | (−): 179, 153, 135 |
| 22 | 2.02 | Hydroxyphenyl glycol gentiobioside | – | – | – | 477.16102 | 477.16136 | 0.72 | C20H30O13 | (−): 315 |
| 23 | 2.07 | Deacetylasperulosidic acid | 391.12465 | 391.12349 | −2.98 | 389.10885 | 389.10894 | 0.22 | C16H22O11 | (−):227 |
| 24 | 2.14 | 6-O-Galloylglucose | – | – | – | 331.06695 | 331.06707 | 0.36 | C13H16O10 | (−): 169 |
| 25 | 2.20 | Amygdalin amide | 476.17776 | 476.17625 | −3.16 | 520.16691 | 520.16718 | 0.52c | C20H29NO12 | (−): 474, 312 |
| 26 | 2.26 | Dihydroxybenzoic acid glucoside | – | – | – | 315.07201 | 315.07216 | 0.46c | C12H16O7 | (−): 153, 109 |
| 27 | 2.31 | Vanillic acid hexose | 331.10343 | 331.10236 | −3.24 | 329.08769 | 329.08781 | 0.36 | C14H18O9 | (−): 167 |
| 28 | 2.34 | Unknown | 314.12402 | 314.12343 | −1.88 | 312.10888 | 312.10888 | 0.00 | C14H19NO7 | – |
| 29 | 2.34 | Geniposidic acid | – | – | – | 373.11395 | 373.11402 | 0.20 | C16H22O10 | (−): 211 |
| 30 | 2.46 | Norephedrine-glucose isomer | 314.16028 | 314.15981 | −1.47 | – | – | – | C15H23NO6 | (+): 152, 134 |
| 31 | 2.56 | Hydroxytyrosol glucoside isomer | 317.12381 | 317.12309 | −2.26 | 315.10840 | 315.10854 | 0.44 | C14H20O8 | (−): 179, 153, 135 |
| 32 | 2.57 | Ephedrine-glucose isomer | 328.17536 | 328.17546 | 0.33 | – | – | – | C16H25NO6 | (+): 166, 148 |
| 33 | 2.58 | (−)-5-O-(4-O-β-D-glucopyranosylcaffeoyl) quinic acid | 517.15662 | 517.15518 | −2.78 | 515.14023 | 515.14063 | 0.77 | C22H28O14 | (−): 191, 179, 135 |
| 34 | 2.65 | Dihydroxybenzoic acid glucoside | – | – | – | 315.07194 | 315.07216 | 0.67 | C13H16O9 | (−): 153, 109 |
| 35 | 2.65 | Amygdalinic acid isomer | – | – | – | 475.14533 | 475.14571 | 0.82 | C20H28O13 | (−): 269 |
| 36 | 2.68 | Norephedrine-glucose | 314.16020 | 314.15981 | −1.23 | – | – | – | C15H23NO6 | (+): 152, 134 |
| 37 | 2.73 | Hydroxyphenyl glycol gentiobioside | – | – | – | 477.16127 | 477.16136 | 0.19 | C20H30O13 | (−): 315 |
| 38 | 2.78 | Ephedrine-glucose | 328.17512 | 328.17546 | 1.04 | – | – | – | C16H25NO6 | (+): 166, 148 |
| 39 | 2.84 | 8-Epiloganic acid | 399.12672 | 399.12617 | −1.39a | 375.12950 | 375.12967 | 0.47 | C16H24O10 | (−): 213 |
| 40 | 2.97 | Syringic acid-O-glucoside | – | – | – | 359.09846 | 359.09837 | −0.25 | C15H20O10 | (−): 197 |
| 41 | 3.00 | (−)-3-O-(4-O-β-D-glucopyranosylcaffeoyl) quinic acid | 517.15555 | 517.15518 | −0.71 | 515.14061 | 515.14063 | 0.03 | C22H28O14 | (−): 353, 191, 179, 135 |
| 42 | 3.04 | Gallocatechin | – | – | – | 305.06666 | 305.06668 | 0.06 | C15H14O7 | (−): 137, 125 |
| 43 | 3.15 | Ephedrine or pseudoephedrine | 166.12289 | 166.12264 | −1.48 | – | – | – | C10H15NO | (+): 148 |
| 44 | 3.19 | Pyrocatechol | – | – | – | 153.01918 | 153.01933 | 1.01c | C6H6O2 | (−): 109 |
| 45 | 3.20 | Phaseoloidin | – | – | – | 329.08776 | 329.08781 | 0.13 | C14H18O9 | – |
| 46 | 3.24 | Syringic acid-O-glucoside | – | – | – | 359.09842 | 359.09837 | −0.15 | C15H20O10 | (−): 197 |
| 47 | 3.24 | Caffeoyl quinic acid butyl ester | – | – | – | 409.15078 | 409.15041 | −0.91 | C20H26O9 | (−): 353, 191, 179, 135 |
| 48 | 3.37 | Amygdalinic acid | 499.14266 | 499.14221 | −0.91a | 475.14551 | 475.14571 | 0.43 | C20H28O13 | (−): 269 |
| 49 | 3.38 | Forsythoside E isomer | 463.18144 | 463.18100 | −0.94 | 461.16627 | 461.16645 | 0.39 | C20H30O12 | (−): 315 |
| 50 | 3.46 | Neochlorogenic acid | 355.10241 | 355.10236 | −0.15 | 353.08758 | 353.08781 | 0.64 | C16H18O9 | (−): 191, 179, 173, 135 |
| 51 | 3.51 | Rebouoside B | 449.16546 | 449.16535 | −0.24 | 447.15069 | 447.15080 | 0.25 | C19H28O12 | (−): 315, 297, 191, 135 |
| 52 | 3.59 | Caffeic acid-glucoside | – | – | – | 341.08777 | 341.08781 | 0.10 | C15H18O9 | (−): 179, 161, 135 |
| 53 | 3.60 | Dihydrosecologanic acid | – | – | – | 375.12954 | 375.12967 | 0.35 | C16H24O10 | – |
| 54 | 3.60 | Campneoside | 655.22301 | 655.22326 | 0.38 | 653.20845 | 653.20871 | 0.40 | C30H38O16 | (−): 179 |
| 55 | 3.62 | Coniferinoside | – | – | – | 549.18227 | 549.18249 | 0.41c | C22H32O13 | (−): 503, 341 |
| 56 | 3.65 | Benzyl 3-(hydroxymethyl)-1-piperidinecarboxylate | 250.14403 | 250.14377 | −1.03 | – | – | – | C14H19NO3 | – |
| 57 | 3.68 | P-Hydroxyphenacyl-β-D-glucopyranoside | 315.10778 | 315.10744 | −1.08 | 313.09285 | 313.09289 | 0.13 | C14H18O8 | (−): 161, 151 |
| 58 | 3.75 | Unknown | – | – | – | 371.09839 | 371.09837 | −0.06 | C16H20O10 | (−): 163 |
| 59 | 3.76 | Tryptophan | 205.09747 | 205.09715 | −1.55 | – | – | – | C11H12N2O2 | (+):188 |
| 60 | 3.76 | P-Coumaric acid-O-glycoside | 327.10793 | 327.10744 | −1.49 | 325.09290 | 325.09289 | −0.03 | C15H18O8 | (−): 163, 119 |
| 61 | 3.76 | (−)-4-O-(4-O-β-D-glucopyranosylcaffeoyl) quinic acid | 517.15614 | 517.15518 | −1.86 | 515.14053 | 515.14063 | 0.19 | C22H28O14 | (−): 191, 179, 135 |
| 62 | 3.90 | P-Hydroxyphenacyl-β-D-glucopyranoside | 315.10773 | 315.10744 | −0.91 | 313.09281 | 313.09289 | 0.26 | C14H18O8 | (−): 161, 151 |
| 63 | 4.03 | Salidroside | 323.11030 | 323.11012 | −0.53a | 299.11371 | 299.11363 | −0.27 | C14H20O7 | (+): 301 |
| 64 | 4.07 | Aucubin | – | – | – | 345.11894 | 345.11911 | 0.49 | C15H22O9 | (−): 183 |
| 65 | 4.14 | Methylephedrine or methylpseudoephedrine | 180.13858 | 180.13829 | −1.63 | – | – | – | C11H17NO | (+): 162 |
| 66 | 4.28 | Forsythoside E | 463.18165 | 463.18100 | −1.39 | 461.16594 | 461.16645 | 1.11 | C20H30O12 | (−): 315 |
| 67 | 4.29 | Ephedrine-glucose isomer | 328.17548 | 328.17546 | −0.03 | – | – | – | C16H25NO6 | (+): 166, 148 |
| 68 | 4.41 | Esculin | 341.08698 | 341.08671 | −0.80 | 339.07203 | 339.07216 | 0.36 | C15H16O9 | (+): 179 |
| 69 | 4.42 | P-Coumaric acid-O-glycoside isomer | – | – | – | 325.09277 | 325.09289 | 0.36 | C15H18O8 | (−): 163 |
| 70 | 4.45 | Crenulatanoside B | 519.24300 | 519.24360 | 1.17 | 517.22860 | 517.22905 | 0.87 | C24H38O12 | (+): 271 |
| 71 | 4.46 | Crenulatin | 249.13365 | 249.13326 | −1.55 | 293.12399 | 293.12419 | 0.69c | C11H20O6 | (−): 247 |
| 72 | 4.53 | Amygdalin amide isomer | – | – | – | 474.16161 | 474.16170 | 0.19 | C20H29NO12 | – |
| 73 | 4.64 | Loganic acid | 399.12662 | 399.12617 | −1.14a | 375.12957 | 375.12967 | 0.27 | C16H24O10 | (−): 213 |
| 74 | 4.66 | Benzyl-4-(hydroxymethyl)piperidin-1-carboxylate | 250.14408 | 250.14377 | −1.23 | – | – | – | C14H19NO3 | – |
| 75 | 4.69 | Syringinoside | 557.18518 | 557.18408 | −1.99a | 579.19288 | 579.19306 | 0.30c | C23H34O14 | (−): 533 |
| 76 | 4.74 | Dopacetic acid-O-rutinoside | – | – | – | 475.14562 | 475.14571 | 0.20 | C20H28O13 | – |
| 77 | 4.76 | Salicin or isomer | – | – | – | 285.09793 | 285.09798 | 0.16 | C13H18O7 | – |
| 78 | 4.91 | Kingiside | 405.13961 | 405.13914 | −1.17 | 449.12964 | 449.13006 | 0.94c | C17H24O11 | (−): 403, 241 |
| 79 | 4.92 | Dihydromelilotoside or isomer | – | – | – | 327.10854 | 327.10854 | 0.00 | C15H20O8 | (−): 165 |
| 80 | 4.94 | Protocatechualdehyde | – | – | – | 137.02429 | 137.02442 | 0.95 | C7H6O3 | – |
| 81 | 4.98 | Suspensaside C isomer | 461.16624 | 461.16535 | −1.92 | 459.15073 | 459.15080 | 0.15 | C20H28O12 | – |
| 82 | 5.01 | Isaindigodione isomer | 327.13433 | 327.13393 | −1.22 | – | – | – | C18H18N2O4 | (+): 201 |
| 83 | 5.02 | Coniferin | 365.12113 | 365.12069 | −1.21a | 387.12956 | 387.12967 | 0.29c | C16H22O8 | (−): 341, 179 |
| 84 | 5.05 | 4-Methoxyphenethyl β-D-glucopyranoside | – | – | – | 313.12920 | 313.12928 | 0.24 | C15H22O7 | – |
| 85 | 5.16 | Darendoside A | – | – | – | 431.15564 | 431.15589 | 0.56 | C19H28O11 | (−): 387, 299, 251, 191, 149 |
| 86 | 5.17 | Suspensaside C | 461.16627 | 461.16535 | −1.99 | 459.15068 | 459.15080 | 0.26 | C20H28O12 | (−): 205, 163, 151 |
| 87 | 5.27 | P-Coumaric acid-O-glycoside isomer | – | – | – | 325.09266 | 325.09289 | 0.71 | C15H18O8 | (−): 163 |
| 88 | 5.30 | Morroniside | 429.13789 | 429.13673 | −2.69a | 451.14532 | 451.14571 | 0.87c | C17H26O11 | (−): 405, 243, 225, 179 |
| 89 | 5.31 | 3-p-Coumaroylquinic acid | 339.10802 | 339.10744 | −1.68 | 337.09270 | 337.09289 | 0.56 | C16H18O8 | (−): 191, 163 |
| 90 | 5.35 | Ferruginoside B | 479.17609 | 479.17592 | −0.36 | 477.16092 | 477.16136 | 0.94 | C20H30O13 | (−): 431, 269 |
| 91 | 5.35 | Darendoside A isomer | 433.16975 | 433.17044 | 1.59 | 431.15558 | 431.15589 | 0.70 | C19H28O11 | (−): 387, 299, 251, 191, 149, 101 |
| 92 | 5.37 | Isaindigodione | 327.13449 | 327.13393 | −1.71 | – | – | – | C18H18N2O4 | (+): 201 |
| 93 | 5.38 | P-Coumaroyltartaric acid | – | – | – | 295.04555 | 295.04594 | 1.31 | C13H12O8 | (−): 163 |
| 94 | 5.38 | Di-galloyl-O-glucose | – | – | – | 483.07769 | 483.07803 | 0.70 | C20H20O14 | – |
| 95 | 5.41 | 7-Epiloganin | – | – | – | 389.14512 | 389.14532 | 0.52 | C17H26O10 | (−): 181, 166 |
| 96 | 5.42 | P-Anisic acid | – | – | – | 151.03990 | 151.04007 | 1.09 | C8H8O3 | – |
| 97 | 5.44 | Unknown | 354.19096 | 354.19111 | 0.43 | – | – | – | C18H27NO6 | (+): 192, 174 |
| 98 | 5.48 | P-coumaroyl-shikimaroylquinic acid | – | – | – | 511.14534 | 511.14571 | 0.74 | C23H28O13 | (−): 337 |
| 99 | 5.56 | Syringin | 390.17627 | 390.17586 | −1.06b | 417.13989 | 417.14024 | 0.82c | C17H24O9 | (−): 371, 209 |
| 100 | 5.59 | Chlorogenic acidd | 355.10244 | 355.10236 | −0.24 | 353.08750 | 353.08781 | 0.87 | C16H18O9 | (−): 191, 179, 173, 135 |
| 101 | 5.65 | Unknown | – | – | – | 743.20283 | 743.20402 | 1.59 | C32H40O20 | (−): 191 |
| 102 | 5.68 | Unknown | 395.21739 | 395.21766 | 0.70 | – | – | – | C20H30N2O6 | (+): 377, 359, 267, 252, 216 |
| 103 | 5.69 | Secologanoside | 391.12424 | 391.12349 | −1.92 | 389.10856 | 389.10894 | 0.96 | C16H22O11 | (−): 345, 183 |
| 104 | 5.71 | Indican | 296.11362 | 296.11286 | −2.55 | 340.10341 | 340.10379 | 1.12c | C14H17NO6 | (−): 294, 132 |
| 105 | 5.72 | Catechin | – | – | – | 289.07182 | 289.07176 | −0.20 | C15H14O6 | (−): 245, 203 |
| 106 | 5.75 | Norisoboldine isomer | 314.13933 | 314.13868 | −2.05 | – | – | – | C18H19NO4 | – |
| 107 | 5.78 | Creoside I | 305.15990 | 305.15948 | −1.38 | 349.15011 | 349.15041 | 0.85c | C14H24O7 | (−): 303 |
| 108 | 5.82 | Cryptochlorogenic acid | 355.10282 | 355.10236 | −1.30 | 353.08754 | 353.08781 | 0.75 | C16H18O9 | (−): 191, 179, 173, 135 |
| 109 | 5.82 | Secologanic acid | 375.12955 | 375.12857 | −2.60 | 373.11355 | 373.11402 | 1.27 | C16H22O10 | (−): 193, 149 |
| 110 | 5.90 | Phthalic acid | – | – | – | 165.01917 | 165.01933 | 1.01 | C8H6O4 | – |
| 111 | 5.91 | 5-O-Feruloylquinic acid | – | – | – | 367.10296 | 367.10346 | 1.36 | C17H20O9 | (−): 193, 173, 149 |
| 112 | 5.96 | Amygdalin | 475.19349 | 475.19224 | −2.64b | 456.15077 | 456.15113 | 0.81 | C20H27NO11 | (−): 323 |
| 113 | 5.98 | Secoxyloganin | 405.14006 | 405.13914 | −2.29 | 449.12935 | 449.13006 | 1.59c | C17H24O11 | – |
| 114 | 6.04 | Creoside I isomer | 305.15946 | 305.15948 | 0.06 | 349.15010 | 349.15041 | 0.87c | C14H24O7 | (−): 303 |
| 115 | 6.04 | Licoagroside B | 433.13518 | 433.13405 | −2.61 | 431.11917 | 431.11950 | 0.76 | C18H24O12 | (+): 127 |
| 116 | 6.05 | 3,4-Dihydroxy cinnamic acid glycerol ester | 255.08678 | 255.08631 | −1.83 | 253.07155 | 253.07176 | 0.85 | C12H14O6 | – |
| 117 | 6.09 | Rhodioloside D | 373.18408 | 373.18329 | −2.12a | 395.19190 | 395.19227 | 0.95c | C16H30O8 | (−): 349 |
| 118 | 6.13 | Norisoboldine | 314.13928 | 314.13868 | −1.89 | – | – | – | C18H19NO4 | (+): 297, 265, 237 |
| 119 | 6.17 | Esculetind | – | – | – | 177.01912 | 177.01933 | 1.21 | C9H6O4 | (−): 149, 133 |
| 120 | 6.19 | Dihydromelilotoside or isomer | – | – | – | 327.10834 | 327.10854 | 0.63 | C15H20O8 | (−): 165 |
| 121 | 6.19 | 8-Epiloganin | – | – | – | 435.15055 | 435.15080 | 0.58c | C17H26O10 | (−): 389 |
| 122 | 6.19 | Clemastanin B | 685.27192 | 685.27021 | −2.49 | 729.25947 | 729.26114 | 2.29c | C32H44O16 | (−): 521 |
| 123 | 6.21 | Caffeic acidd | – | – | – | 179.03477 | 179.03498 | 1.17 | C9H8O4 | (−):135 |
| 124 | 6.21 | Coclaurine | 286.14416 | 286.14377 | −1.37 | – | – | – | C17H20NO3 | (+): 107 |
| 125 | 6.24 | Quercetin-O-rhamnoside-glucoside | 611.16310 | 611.16066 | −3.99 | 609.14535 | 609.14611 | 1.24 | C27H30O16 | (−): 447, 301 |
| 126 | 6.25 | Benzyl β-primeveroside | 403.16021 | 403.15987 | −0.83 | 401.14506 | 401.14532 | 0.65 | C18H26O10 | (−): 269 |
| 127 | 6.25 | Dai-tunicamine | – | – | – | 431.19187 | 431.19227 | 0.92 | C20H32O10 | – |
| 128 | 6.28 | Unknown | – | – | – | 447.15013 | 447.15080 | 1.51 | C19H28O12 | (−): 285 |
| 129 | 6.35 | Creoside II | – | – | – | 351.16588 | 351.16606 | 0.51c | C14H26O7 | (−): 305, 179 |
| 130 | 6.36 | Luteolin-O-arabinopyranosyl-glucopyranoside | – | – | – | 579.13504 | 579.13554 | 0.87 | C26H28O15 | – |
| 131 | 6.39 | Loganin | – | – | – | 435.15045 | 435.15080 | 0.79c | C17H26O10 | (−): 389, 227 |
| 132 | 6.42 | L-Stepholidine | 328.15500 | 328.15433 | −2.02 | – | – | – | C19H22NO4 | (+): 297 |
| 133 | 6.42 | Kaempferol-3-O-rutinoside isomer | 595.16807 | 595.16575 | −3.90 | 593.15080 | 593.15119 | 0.67 | C27H30O15 | – |
| 134 | 6.43 | Geniposide | 411.12688 | 411.12617 | −1.73a | 433.13507 | 433.13515 | 0.19c | C17H24O10 | (−): 225, 207 |
| 135 | 6.44 | Lariciresinol-4′-O-β-D-glucoside | – | – | – | 521.20278 | 521.20284 | 0.10 | C26H34O11 | (−): 359 |
| 136 | 6.46 | Roseoside | 387.20223 | 387.20134 | −2.28 | 431.19199 | 431.19227 | 0.66c | C19H30O8 | (−): 385 |
| 137 | 6.48 | 1-Phenyl-1-propen-2-amine-xylose | 264.12346 | 264.12303 | −1.59 | – | – | – | C14H17NO4 | – |
| 138 | 6.50 | Sweroside | 359.13412 | 359.13366 | −1.30 | 403.12418 | 403.12459 | 1.01c | C16H22O9 | (+): 197, 179, 127 |
| 139 | 6.50 | (R)-Suspensaside | – | – | – | 639.19244 | 639.19306 | 0.97 | C29H36O16 | (−): 459 |
| 140 | 6.52 | Purpureaside C | – | – | – | 785.25062 | 785.25097 | 0.44 | C35H46O20 | (−): 623 |
| 141 | 6.58 | Magnoflorine | 342.17084 | 342.16998 | −2.50 | – | – | – | C20H24NO4+ | (+): 297, 265 |
| 142 | 6.58 | Norephedrine-glucose-malonyl | 400.16113 | 400.16021 | −2.29 | – | – | – | C18H25NO9 | (+): 152, 134 |
| 143 | 6.59 | 4-p-Coumaroylquinic acid | 339.10810 | 339.10744 | −1.94 | 337.09270 | 337.09289 | 0.58 | C16H18O8 | (−): 191, 163 |
| 144 | 6.65 | Caffeoylmalic acid | – | – | – | 295.04558 | 295.04594 | 1.22 | C13H12O8 | (−): 179, 133 |
| 145 | 6.65 | Anthranilic acid-7-O-β-D-glucopyranose ester | 300.10827 | 300.10778 | −1.64 | 298.09300 | 298.09323 | 0.76 | C13H17NO7 | (−): 280, 262, 244, 136 |
| 146 | 6.66 | 3,4-Dicaffeoyl quinic acid isomer | 517.13521 | 517.13405 | −2.24 | 515.11896 | 515.11950 | 1.04 | C25H24O12 | (−): 353, 191, 179, 135 |
| 147 | 6.69 | 2-Hydroxy-1,4-phthalic acid | – | – | – | 181.01403 | 181.01425 | 1.19 | C8H6O5 | (−): 137 |
| 148 | 6.71 | Pinoresinol diglucoside | – | – | – | 681.23921 | 681.24001 | 1.17 | C32H42O16 | (−): 519, 357 |
| 149 | 6.76 | Echinacoside | – | – | – | 785.25007 | 785.25097 | 1.14 | C35H46O20 | (−): 623, 477, 461, 315, 179, 161 |
| 150 | 6.78 | Forsythoside C | – | – | – | 639.19250 | 639.19306 | 0.87 | C29H36O16 | (−): 161, 135 |
| 151 | 6.78 | Prunasin | 296.11321 | 296.11286 | −1.17 | 340.10353 | 340.10379 | 0.77c | C14H17NO6 | (−): 161 |
| 152 | 6.79 | Pyrocatechol | – | – | – | 153.01913 | 153.01933 | 1.33c | C6H6O2 | (−): 109 |
| 153 | 6.89 | Lugrandoside | 641.20954 | 641.20761 | −3.01 | 639.19223 | 639.19306 | 1.30 | C29H36O16 | (−): 179, 161 |
| 154 | 6.92 | P-Coumaric acid-O-glycoside isomer | – | – | – | 325.09285 | 325.09289 | 0.13 | C15H18O8 | (−): 163 |
| 155 | 6.92 | 6′-O-galloylsalidroside or isomer | 453.13833 | 453.13914 | 1.78 | 451.12420 | 451.12459 | 0.85 | C21H24O11 | – |
| 156 | 6.93 | 7-Deoxyloganin | – | – | – | 373.15005 | 373.15041 | 0.96 | C17H26O9 | – |
| 157 | 6.93 | Schaftoside | 565.15698 | 565.15518 | −3.18 | 563.13990 | 563.14063 | 1.30 | C26H28O14 | (−): 503, 473, 443, 413, 383, 353 |
| 158 | 6.94 | Rhododendrol-2-O-β-D-glucopyranoside | – | – | – | 327.14468 | 327.14493 | 0.76 | C16H24O7 | (−): 165 |
| 159 | 6.96 | 3-O-Feruloylquinic acid | 369.11856 | 369.11801 | −1.50 | 367.10316 | 367.10346 | 0.80 | C17H20O9 | (−): 193, 173, 149 |
| 160 | 6.98 | Epicatechin gallate | 443.09653 | 443.09727 | 1.68 | – | – | – | C22H18O10 | (+): 291, 255 |
| 161 | 6.99 | Secologanoside-7-methyl ester | 405.13994 | 405.13914 | −1.98 | 403.12417 | 403.12459 | 1.03 | C17H24O11 | (−): 371, 223, 121 |
| 162 | 7.04 | β-Hydroxyacteoside | – | – | – | 639.19195 | 639.19306 | 1.73 | C29H36O16 | (−): 477, 315, 179, 161, 135 |
| 163 | 7.05 | Unknown | – | – | – | 459.09286 | 459.09329 | 0.92 | C22H20O11 | (−): 253 |
| 164 | 7.07 | Glucoliquiritin apioside | 713.23070 | 713.22874 | −2.75 | 711.21234 | 711.21419 | 2.60 | C32H40O18 | (−): 255 |
| 165 | 7.09 | Liriodendrin | – | – | – | 787.26449 | 787.26662 | 2.71c | C34H46O18 | (−): 741 |
| 166 | 7.17 | (S)-Suspensaside | – | – | – | 639.19262 | 639.19306 | 0.68 | C29H36O16 | (−): 477, 179, 161, 135 |
| 167 | 7.18 | Isoschaftoside | 565.15689 | 565.15518 | −3.02 | 563.13976 | 563.14063 | 1.55 | C26H28O14 | (−): 503, 473, 443, 413, 383, 353 |
| 168 | 7.19 | 2-Phenylethyl-6-O-α-L-arabinofuranosyl-β-D-glucopyranoside | 417.17446 | 417.17552 | 2.55 | 461.16598 | 461.16645 | 1.03c | C19H28O10 | (−): 415 |
| 169 | 7.20 | Caffeoylshikimic acid | – | – | – | 335.07694 | 335.07724 | 0.90 | C16H16O8 | (−): 179, 135 |
| 170 | 7.23 | Vogeloside | – | – | – | 387.12966 | 387.12967 | 0.03 | C17H24O10 | – |
| 171 | 7.24 | Plantainoside A | 479.15572 | 479.15479 | −1.94 | 477.13984 | 477.14024 | 0.82 | C23H26O11 | (−): 179, 161, 135 |
| 172 | 7.26 | L-Phenylalaninosecologanin | 538.22822 | 538.22829 | 0.12 | 536.21316 | 536.21373 | 1.08 | C26H35NO11 | (+): 376, 358 |
| 173 | 7.21 | Liquiritigenin-7-O-apiosyl (1–2)-glucoside | 551.17709 | 551.17592 | −2.13 | – | – | – | C26H30O13 | (+): 257 |
| 174 | 7.29 | 8′-Hydroxypionresinol-4′-O-glucoside | 537.19843 | 537.19665 | −3.32 | 535.18169 | 535.18210 | 0.76 | C26H32O12 | (−): 343 |
| 175 | 7.30 | Deoxyvasicinone | 187.08634 | 187.08659 | 1.31 | – | – | – | C11H10N2O | (+): 146 |
| 176 | 7.30 | 2-Phenylethyl-1-β-D-glucoside | 285.13355 | 285.13326 | −0.99 | 329.12397 | 329.12419 | 0.66c | C14H20O6 | – |
| 177 | 7.32 | Caffeoylshikimic acid | 337.09228 | 337.09179 | −1.45 | 335.07698 | 335.07724 | 0.77 | C16H16O8 | (−): 179, 135 |
| 178 | 7.36 | Dimethyl secologanoside | – | – | – | 417.13986 | 417.14024 | 0.91 | C18H26O11 | (−): 255 |
| 179 | 7.37 | 2-O-(α-L-arabinose)-1-O-hexanoyl-β-D-rhamnose | – | – | – | 393.17632 | 393.17662 | 0.77 | C17H30O10 | (−): 347, 261, 149 |
| 180 | 7.38 | Hydroxyluteolin-O-arabinopyranosyl-glucopyranoside | 597.14677 | 597.14501 | −2.95 | 595.12926 | 595.13046 | 2.01 | C26H28O16 | (−): 301 |
| 181 | 7.42 | Sachalinoside B | 333.19129 | 333.19078 | −1.53 | 377.18137 | 377.18171 | 0.88c | C16H28O7 | – |
| 182 | 7.40 | Secoisolariciresinol 4-O-β-D-glucopyranoside | – | – | – | 523.21791 | 523.21849 | 1.09 | C26H36O11 | (−): 361, 346, 165 |
| 183 | 7.42 | Isolugrandoside | – | – | – | 639.19237 | 639.19306 | 1.08 | C29H36O16 | (−): 477, 315, 179, 161, 135 |
| 184 | 7.45 | Darendroside B | – | – | – | 475.18112 | 475.18210 | 2.06 | C21H32O12 | (−): 329 |
| 185 | 7.45 | Calceolarioside C | 611.19912 | 611.19705 | −3.39 | 609.18145 | 609.18249 | 1.71 | C28H34O15 | (−): 179, 161 |
| 186 | 7.51 | Ethyl gallate | – | – | – | 197.04536 | 197.04555 | 0.96 | C9H10O5 | (−): 169, 125 |
| 187 | 7.51 | Caffeoylshikimic acid | 337.09236 | 337.09179 | −1.68 | 335.07691 | 335.07724 | 1.00 | C16H16O8 | (−): 179, 135 |
| 188 | 7.52 | Plantainoside B | 479.15511 | 479.15479 | −0.67 | 477.13973 | 477.14024 | 1.07 | C23H26O11 | (−): 179, 161, 135 |
| 189 | 7.53 | 4-O-Feruloylquinic acid | 369.11849 | 369.11801 | −1.30 | 367.10344 | 367.10346 | 0.04 | C17H20O9 | (−): 193, 173, 149 |
| 190 | 7.53 | Demethyldihydrophillygenin glucuronide | 537.19757 | 537.19665 | −1.71 | 535.18148 | 535.18210 | 1.17 | C26H32O12 | (−): 373 |
| 191 | 7.56 | Forsythoside B | 779.23975 | 779.23690 | −3.66a | 755.23923 | 755.24040 | 1.55 | C34H44O19 | (−): 593, 461, 447, 161 |
| 192 | 7.64 | Forsythoside H | 625.21341 | 625.21270 | −1.14 | 623.19692 | 623.19814 | 1.96 | C29H36O15 | (−): 477, 461, 443, 315, 297, 179, 161, 135, 133 |
| 193 | 7.70 | Calceolarioside B isomer | 479.15508 | 479.15479 | −0.62 | 477.13956 | 477.14024 | 1.41 | C23H26O11 | (−): 179, 161 |
| 194 | 7.71 | 5′-Methoxy-8′-hydroxyl-(+)-isolariciresinol-4′-O-β-D-glucopyranoside | – | – | – | 567.20728 | 567.20831 | 1.82 | C27H36O13 | (−): 359, 329 |
| 195 | 7.73 | Neoliquiritin | 419.13446 | 419.13366 | −1.91 | 417.11946 | 417.11911 | −0.84 | C21H22O9 | (+): 257 |
| 196 | 7.76 | 5-Carboxymethyl-7-hydroxy-2-methyl-chromone | 235.06002 | 235.06010 | 0.33 | 233.04532 | 233.04555 | 0.98 | C12H10O5 | – |
| 197 | 7.76 | Isoviolanthin | 579.17150 | 579.17083 | −1.16 | 577.15506 | 577.15628 | 2.12 | C27H30O14 | (−): 457, 439, 413, 395, 383, 365, 353, 337, 325, 311, 297 |
| 198 | 7.79 | Norjuziphine | 286.14397 | 286.14377 | −0.70 | – | – | – | C17H20NO3 | (+): 107 |
| 199 | 7.81 | Rutin | 611.16097 | 611.16066 | −0.50 | 609.14530 | 609.14611 | 1.32 | C27H30O16 | (+): 465, 303 |
| 200 | 7.84 | Calycosin-7-glucoside | 447.12918 | 447.12857 | −1.36 | – | – | – | C22H22O10 | (+): 285 |
| 201 | 7.87 | Forsythoside I | 625.21340 | 625.21270 | −1.13 | 623.19775 | 623.19814 | 0.63 | C29H36O15 | (−): 477, 461, 443, 315, 297, 179, 161, 135, 133 |
| 202 | 7.89 | 4-Hydroxycoumarin | 163.03923 | 163.03897 | −1.58 | 161.02417 | 161.02442 | 1.54 | C9H6O3 | – |
| 203 | 7.97 | Liquiritin apioside | 551.17709 | 551.17592 | −2.13 | 549.16066 | 549.16136 | 1.27 | C26H30O13 | (+): 257 |
| 204 | 7.99 | Isovitexin | 433.11335 | 433.11292 | −0.98 | 431.09759 | 431.09837 | 1.81 | C21H20O10 | (+): 415, 397, 379, 367, 361, 351, 349, 337, 323, 313, 309, 295, 283 |
| 205 | 7.99 | Lariciresinol-4-O-glucoside | 545.20051 | 545.19933 | −2.17a | 521.20241 | 521.20284 | 0.82 | C26H34O11 | (−): 359 |
| 206 | 8.00 | Unknown | 398.18129 | 398.18094 | −0.87 | 396.16601 | 396.16639 | 0.97 | C19H27NO8 | (+): 236, 218, 190 |
| 207 | 8.05 | Liquiritin | 419.13402 | 419.13366 | −0.86 | 417.11940 | 417.11911 | −0.71 | C21H22O9 | (+): 257 |
| 208 | 8.07 | Isoquercitrin | 465.10349 | 465.10275 | −1.59 | 463.08760 | 463.08820 | 1.30 | C21H20O12 | (+): 303 |
| 209 | 8.07 | Liquiritigenin-7,4′-diglucoside | 581.18785 | 581.18648 | −2.36 | 579.17011 | 579.17193 | 3.14 | C27H32O14 | (+): 239 |
| 210 | 8.08 | Forsythoside G | – | – | – | 769.25389 | 769.25605 | 2.81 | C35H46O19 | (−): 607 |
| 211 | 8.10 | Calceolarioside A | 479.15525 | 479.15479 | −0.97 | 477.13974 | 477.14024 | 1.04 | C23H26O11 | (−): 179, 161 |
| 212 | 8.13 | Neoamygdalin | – | – | – | 456.15079 | 456.15113 | 0.75 | C20H27NO11 | (−): 323 |
| 213 | 8.17 | Ferulic acid | – | – | – | 193.05044 | 193.05063 | 0.99 | C10H10O4 | (−): 149 |
| 214 | 8.18 | 1-O-trans-Cinnamoyl-beta-D-glucopyranose | 311.11285 | 311.11253 | −1.03 | 355.10311 | 355.10346 | 0.97c | C15H18O7 | (−): 189, 161, 147 |
| 215 | 8.18 | Resveratrol 4′-O-glucoside | – | – | – | 389.12361 | 389.12419 | 1.49 | C20H22O8 | (−): 227 |
| 216 | 8.14 | Rhein-8-O-β-D-glucoside | – | – | – | 445.07800 | 445.07763 | −0.82 | C21H18O11 | (−): 283, 239 |
| 217 | 8.19 | Strychoside A | 745.25615 | 745.25496 | −1.60 | 743.23879 | 743.24040 | 2.17 | C33H44O19 | (−): 511, 479 |
| 218 | 8.20 | Acteoside isomer | 647.19644 | 647.19464 | −2.78a | 623.19694 | 623.19814 | 1.93 | C29H36O15 | (−): 461, 315, 179, 161, 135 |
| 219 | 8.21 | Hyperin | 465.10365 | 465.10275 | −1.92 | 463.08777 | 463.08820 | 0.94 | C21H20O12 | (+): 303 |
| 220 | 8.21 | Kaempferol-3-O-rhamnose-7-O-glucose | 595.16731 | 595.16575 | −2.63 | 593.14994 | 593.15119 | 2.11 | C27H30O15 | (−): 285 |
| 221 | 8.22 | Conicaoside | – | – | – | 551.21249 | 551.21340 | 1.65 | C27H36O12 | – |
| 222 | 8.26 | Rosiridin | 333.19129 | 333.19078 | −1.53 | 377.18125 | 377.18171 | 1.20c | C16H28O7 | – |
| 223 | 8.26 | Scutellarin | 463.08802 | 463.08710 | −1.98 | 461.07191 | 461.07255 | 1.39 | C21H18O12 | (+): 287 |
| 224 | 8.27 | Suspensaside A isomer | 623.19945 | 623.19705 | −3.86 | 621.18146 | 621.18249 | 1.67 | C29H34O15 | (−): 161 |
| 225 | 8.28 | Cynaroside | 449.10878 | 449.10784 | −2.10 | 447.09286 | 447.09329 | 0.96 | C21H20O11 | (−): 285 |
| 226 | 8.30 | 1-Methoxyindole-3-acetamide | 205.09741 | 205.09715 | −1.25 | – | – | – | C11H12N2O2 | (+):188 |
| 227 | 8.34 | Creoside IV | 397.20694 | 397.20682 | −0.29 | 395.19202 | 395.19227 | 0.63 | C17H32O10 | – |
| 228 | 8.38 | Luteolin-7-O-rutinoside | 595.16734 | 595.16575 | −2.68 | 593.15031 | 593.15119 | 1.49 | C27H30O15 | (−): 285 |
| 229 | 8.39 | Rosavin | – | – | – | 473.16680 | 473.16645 | −0.74c | C20H28O10 | (−): 427, 293, 233, 191, 149, 131 |
| 230 | 8.41 | Calceolarioside B | 479.15560 | 479.15479 | −1.69 | 477.13966 | 477.14024 | 1.20 | C23H26O11 | (+): 325, 163 |
| 231 | 8.43 | Rhodioloside E | – | – | – | 511.23891 | 511.23961 | 1.38c | C21H38O11 | – |
| 232 | 8.51 | Isaindigodione isomer | 327.13412 | 327.13393 | −0.57 | – | – | – | C18H18N2O4 | (+): 201 |
| 233 | 8.53 | Forsythenside K isomer | 609.21958 | 609.21778 | −2.95 | 607.20230 | 607.20323 | 1.53 | C29H36O14 | (−): 461 |
| 234 | 8.64 | Suspensaside A | 623.19760 | 623.19705 | −0.89 | 621.18152 | 621.18249 | 1.58 | C29H34O15 | (−): 161 |
| 235 | 8.66 | Forsythoside A | 647.19663 | 647.19464 | −3.07a | 623.19737 | 623.19814 | 1.25 | C29H36O15 | (−): 461, 315, 297, 179, 161, 135 |
| 236 | 8.72 | Nicotiflorin | 595.16730 | 595.16575 | −2.61 | 593.15034 | 593.15119 | 1.44 | C27H30O15 | (+): 287 |
| 237 | 8.73 | 3,4-Dicaffeoyl quinic acid | 517.13515 | 517.13405 | −2.12 | 515.11892 | 515.11950 | 1.13 | C25H24O12 | (−): 353, 191, 179, 135 |
| 238 | 8.82 | Isolariciresinol | 361.16492 | 361.16456 | −0.98 | 405.15504 | 405.15549 | 1.12c | C20H24O6 | (−): 359, 344, 313 |
| 239 | 8.82 | Acteoside | 625.21423 | 625.21270 | −2.45 | 623.19642 | 623.19814 | 2.77 | C29H36O15 | (−): 461, 315, 297, 179, 161, 135, 133 |
| 240 | 8.83 | Luteolin-5-O-glucoside | 449.10877 | 449.10784 | −2.09 | 447.09290 | 447.09329 | 0.86 | C21H20O11 | (+): 287 |
| 241 | 8.85 | Forsythenside K | 609.21862 | 609.21778 | −1.38 | 607.20233 | 607.20323 | 1.48 | C29H36O14 | (−): 461 |
| 242 | 8.91 | Licoflavanone isomer | 341.13847 | 341.13835 | −0.35 | – | – | – | C20H20O5 | (+): 291, 263 |
| 243 | 8.93 | Pinoresinol-4-O-glucoside | 543.18472 | 543.18368 | −1.91a | 519.18642 | 519.18719 | 1.48 | C26H32O11 | (−): 357, 342, 151 |
| 244 | 8.95 | Rhodioloside A | 371.16804 | 371.16764 | −1.08a | 347.17090 | 347.17114 | 0.69 | C16H28O8 | (+): 203 |
| 245 | 8.96 | Rhodiolgin | 465.10353 | 465.10275 | −1.67 | 463.08778 | 463.08820 | 0.91 | C21H20O12 | (−): 317, 303 |
| 246 | 9.02 | n-Hexyl-β-D-glucopyranoside | 287.14678 | 287.14651 | −0.96a | 309.15531 | 309.15549 | 0.59c | C12H24O6 | – |
| 247 | 9.08 | Leucosceptoside A | 639.23032 | 639.22835 | −3.09 | 637.21288 | 637.21379 | 1.43 | C30H38O15 | (−): 461, 175 |
| 248 | 9.10 | 3,5-Dicaffeoyl quinic acid | 517.13509 | 517.13405 | −2.01 | 515.11886 | 515.11950 | 1.23 | C25H24O12 | (−): 353, 191, 179, 135 |
| 249 | 9.14 | Acanthoside B | 603.20614 | 603.20481 | −2.21a | 579.20778 | 579.20831 | 0.93 | C28H36O13 | (−): 417, 402 |
| 250 | 9.26 | Rhoifolin | 579.17222 | 579.17083 | −2.40 | 577.15722 | 577.15628 | −1.63 | C27H30O14 | (+): 271 |
| 251 | 9.30 | Quercitrin | 449.10818 | 449.10784 | −0.77 | 447.09270 | 447.09329 | 1.30 | C21H20O11 | (−): 301, 285, 284, 271, 255 |
| 252 | 9.37 | Centauroside | 759.27302 | 759.27061 | −3.18 | 757.25408 | 757.25605 | 2.61 | C34H46O19 | (−): 595, 525, 493 |
| 253 | 9.45 | Isorhamnetin-3-O-glucoside | 479.11912 | 479.11840 | −1.50 | 477.10325 | 477.10385 | 1.26 | C22H22O12 | (+): 317 |
| 254 | 9.49 | Choerospondin | 435.12890 | 435.12857 | −0.75 | 433.11374 | 433.11402 | 0.65 | C21H22O10 | (+): 273 |
| 255 | 9.52 | Apigenin-7-O-glucoside | 433.11352 | 433.11292 | −1.37 | 431.09768 | 431.09837 | 1.61 | C21H20O10 | (+): 271 |
| 256 | 9.60 | Hesperidin | – | – | – | 609.18085 | 609.18249 | 2.70 | C28H34O15 | (−): 301 |
| 257 | 9.64 | Acacetin-6,8-di-C-glucoside | 609.18290 | 609.18140 | −2.47 | 607.16628 | 607.16684 | 0.93 | C28H32O15 | – |
| 258 | 9.68 | 4,5-Dicaffeoyl quinic acid | 517.13470 | 517.13405 | −1.24 | 515.11866 | 515.11950 | 1.64 | C25H24O12 | (−): 353, 191, 179, 135 |
| 259 | 9.73 | Indole-3-acetonitrile-2-S-β-D-glucopyranoside | 351.10150 | 351.10092 | −1.65 | 349.08603 | 349.08637 | 0.96 | C16H18N2O5S | (−): 187, 160 |
| 260 | 9.81 | (7R,8S,7′R,8′S)-5-Methoxyprinsepiol-4-O-β-D-glucose | 583.20347 | 583.20213 | −2.29 | 581.18690 | 581.18758 | 1.16 | C27H34O14 | (−): 419, 371, 223 |
| 261 | 9.82 | Azelaic acid | 189.11208 | 189.11214 | 0.29 | 187.09736 | 187.09758 | 1.18 | C9H16O4 | (−): 125 |
| 262 | 9.85 | Salicylic acid | – | – | – | 137.02428 | 137.02442 | 1.02 | C7H6O3 | – |
| 263 | 9.88 | Pratensein-7-O-glucoside isomer | 463.12422 | 463.12349 | −1.58 | 461.10903 | 461.10894 | −0.21 | C22H22O11 | (+): 301 |
| 264 | 9.88 | (E)-Aldosecologanin | 759.27028 | 759.27061 | 0.43 | 757.25436 | 757.25605 | 2.24 | C34H46O19 | (−): 595, 525, 493 |
| 265 | 10.00 | Rosin | – | – | – | 341.12382 | 341.12419 | 1.09c | C15H20O6 | – |
| 266 | 10.02 | Kaempferol-3-O-rutinoside isomer | 595.16699 | 595.16575 | −2.10 | 593.15050 | 593.15119 | 1.17 | C27H30O15 | (−): 285 |
| 267 | 10.06 | Unknown | 506.23943 | 506.23846 | −1.93 | – | – | – | C26H35NO9 | (+): 344, 326 |
| 268 | 10.08 | 6-Hydroxymusizin-8-O-β-D-glucopyranoside | 395.13394 | 395.13366 | −0.71 | 393.11872 | 393.11911 | 0.99 | C19H22O9 | (−): 231 |
| 269 | 10.13 | Rhododendrol-2-O-β-D-glucopyranoside isomer | 329.15996 | 329.15948 | −1.46 | 327.14463 | 327.14493 | 0.90 | C16H24O7 | – |
| 270 | 10.16 | P-Coumarin caffeoylquinic acid | 501.14029 | 501.13914 | −2.30 | 499.12405 | 499.12459 | 1.08 | C25H24O11 | (−): 353, 337, 191, 179 |
| 271 | 10.26 | Rhapontin | – | – | – | 419.13439 | 419.13476 | 0.88 | C21H24O9 | – |
| 272 | 10.26 | Crenatoside | 623.19760 | 623.19705 | −0.89 | 621.18149 | 621.18249 | 1.62 | C29H34O15 | (−): 161 |
| 273 | 10.30 | 8-Hydroxypinoresinol | 375.14425 | 375.14383 | −1.13 | 373.12900 | 373.12928 | 0.74 | C20H22O7 | (−): 313 |
| 274 | 10.36 | Epi-pinoresinol | 359.14922 | 359.14891 | −0.85 | 357.13402 | 357.13436 | 0.96 | C20H22O6 | (−): 342 |
| 275 | 10.39 | 8-Hydroxysyringaresinol | 435.16555 | 435.16496 | −1.35 | 433.15040 | 433.15041 | 0.01 | C22H26O9 | (−): 403, 385, 373, 358, 343, 325 |
| 276 | 10.39 | Pinoresinol-4-O-glucoside isomer | 543.18459 | 543.18368 | −1.67a | 519.18658 | 519.18719 | 1.16 | C26H32O11 | (−): 357, 342 |
| 277 | 10.43 | Secoisolariciresinol | – | – | – | 361.16522 | 361.16566 | 1.21 | C20H26O6 | (−): 346, 165 |
| 278 | 10.43 | Sachaloside II | 469.20530 | 469.20442 | −1.88a | 491.21283 | 491.21340 | 1.15c | C21H34O10 | (−): 445 |
| 279 | 10.48 | Luteolin-7-O-α-L-rhamnoside | – | – | – | 431.09793 | 431.09837 | 1.03 | C21H20O10 | (−): 285 |
| 280 | 10.49 | 3,5-O-dicaffeoylquinic acid methyl ester | 531.14933 | 531.14970 | 0.70 | 529.13459 | 529.13515 | 1.05 | C26H26O12 | (−): 191, 173 |
| 281 | 10.50 | Hydroxymedioresinol | 405.15482 | 405.15439 | −1.04 | 403.13953 | 403.13984 | 0.77 | C21H24O8 | (−): 343 |
| 282 | 10.53 | Isoliquiritin apioside | 551.17675 | 551.17592 | −1.51 | 549.16082 | 549.16136 | 0.99 | C26H30O13 | (+): 257 |
| 283 | 10.54 | Glycyroside | 563.17681 | 563.17592 | −1.58 | 561.16086 | 561.16136 | 0.90 | C27H30O13 | (+): 269 |
| 284 | 10.55 | Chrysoeriol-7-O-neohesperidoside | – | – | – | 607.16565 | 607.16684 | 1.97 | C28H32O15 | – |
| 285 | 10.57 | 7-O-ethyl-sweroside | – | – | – | 401.14496 | 401.14532 | 0.89 | C18H26O10 | (−): 233, 215, 197, 175 |
| 286 | 10.57 | Leucosceptoside A or isomer | 639.22838 | 639.22835 | −0.05 | 637.21287 | 637.21379 | 1.46 | C30H38O15 | (−): 461 |
| 287 | 10.59 | Pratensein-7-O-glucoside | 463.12435 | 463.12349 | −1.86 | 461.10846 | 461.10894 | 1.04 | C22H22O11 | (−): 299, 284 |
| 288 | 10.66 | Genistin | 433.11338 | 433.11292 | −1.06 | 431.09800 | 431.09837 | 0.86 | C21H20O10 | (−): 269 |
| 289 | 10.66 | Oleuropein | – | – | – | 539.17665 | 539.17701 | 0.68 | C25H32O13 | (−): 377, 345, 327, 307, 275 |
| 290 | 10.67 | Tricin 7-O-glucoside | 493.13463 | 493.13405 | −1.17 | 491.11918 | 491.11950 | 0.65 | C23H24O12 | – |
| 291 | 10.73 | Indole-3-acetonitrile-4-methoxy-2-S-β-D-glucopyranoside or N-Methoxyindole-3-acetonitrile-2-S-β-D-glucopyranoside | 381.11204 | 381.11148 | −1.46 | 379.09664 | 379.09693 | 0.76 | C17H20N2O6S | (+): 219 |
| 292 | 10.88 | Isoliquiritin apioside isomer | 551.17690 | 551.17592 | −1.78 | 549.16083 | 549.16136 | 0.97 | C26H30O13 | (+): 257 |
| 293 | 10.88 | Rhodiosin | 611.16141 | 611.16066 | −1.23 | 609.14512 | 609.14611 | 1.63 | C27H30O16 | (−): 301 |
| 294 | 10.91 | 8-O-Methylretusin-7-O-β-D-glucopyranoside | 461.14485 | 461.14422 | −1.36 | 459.12925 | 459.12967 | 0.91 | C23H24O10 | (+): 299 |
| 295 | 10.96 | Lariciresinol | 361.16492 | 361.16456 | −0.98 | 405.15509 | 405.15549 | 1.00c | C20H24O6 | (−): 329.13917 |
| 296 | 10.96 | Unknown | – | – | – | 459.09293 | 459.09329 | 0.78 | C22H20O11 | (−): 253 |
| 297 | 11.03 | 4,5-O-dicaffeoylquinic acid methyl ester | – | – | – | 529.13432 | 529.13515 | 1.57 | C26H26O12 | (−): 179, 173 |
| 298 | 11.04 | Isoliquiritin | 419.13408 | 419.13366 | −1.01 | 417.11866 | 417.11911 | 1.08 | C21H22O9 | (+): 257 |
| 299 | 11.04 | Pratensein-7-O-glucoside isomer | – | – | – | 461.10848 | 461.10894 | 1.00 | C22H22O11 | (−): 299, 284 |
| 300 | 11.05 | Flavoyadorinin B | – | – | – | 475.12417 | 475.12459 | 0.88 | C23H24O11 | (−): 283 |
| 301 | 11.06 | Ononin | 431.13390 | 431.13366 | −0.55 | 429.11941 | 429.11911 | −0.71 | C22H22O9 | (+): 269 |
| 302 | 11.18 | Lonijapospiroside A | – | – | – | 560.17670 | 560.17735 | 1.15 | C27H31NO12 | (−): 296 |
| 303 | 11.22 | Arctiin isomer | 557.20019 | 557.19933 | −1.53a | 579.20762 | 579.20831 | 1.20c | C27H34O11 | (−): 371 |
| 304 | 11.25 | 3-(2′-Hydroxyphenyl)-4-(3H)-quinazolinone | 239.08175 | 239.08150 | −1.03 | – | – | – | C14H10N2O2 | – |
| 305 | 11.28 | N-p-Coumaroyltyramine | 284.12839 | 284.12812 | −0.95 | – | – | – | C17H17NO3 | (+): 147 |
| 306 | 11.29 | 7,4′-Dihydroxyflavone | 255.06527 | 255.06519 | −0.35 | 253.05057 | 253.05063 | 0.25 | C15H10O4 | (+): 137 |
| 307 | 11.43 | Rhodiolatuntoside | 449.10804 | 449.10784 | −0.45 | 447.09289 | 447.09329 | 0.88 | C21H20O11 | (−): 151 |
| 308 | 11.44 | Neoisoliquiritin | 419.13413 | 419.13366 | −1.12 | 417.11881 | 417.11911 | 0.71 | C21H22O9 | (+): 257 |
| 309 | 11.58 | 3,4-O-dicaffeoylquinic acid methyl ester | 531.15067 | 531.14970 | −1.82 | 529.13454 | 529.13515 | 1.15 | C26H26O12 | (−): 191, 179, 173 |
| 310 | 11.60 | Unknown | 553.19237 | 553.19157 | −1.46 | 551.17597 | 551.17701 | 1.90 | C26H32O13 | (+): 391, 373, 347 |
| 311 | 11.63 | Licorice glycoside D1/D2 | 697.21387 | 697.21270 | −1.68 | 695.19746 | 695.19814 | 0.99 | C35H36O15 | (−): 549, 531, 417, 399, 255 |
| 312 | 11.70 | 1-O-Galloy1-2-O-cinnamoylglucose | – | – | – | 461.10849 | 461.10894 | 0.97 | C22H22O11 | (−): 313, 169 |
| 313 | 11.70 | Crenuloside | 595.16654 | 595.16575 | −1.34 | 593.15061 | 593.15119 | 0.98 | C27H30O15 | (+): 287 |
| 314 | 11.75 | Licorice glycoside C1/C2 | 727.22455 | 727.22326 | −1.77 | 725.20724 | 725.20871 | 2.03 | C36H38O16 | (−): 255 |
| 315 | 11.82 | Licochalcone B | 287.09170 | 287.09140 | −1.04 | 285.07669 | 285.07685 | 0.55 | C16H14O5 | (−): 270, 177, 150 |
| 316 | 11.83 | N-transferuloyltyramine | 314.13899 | 314.13868 | −0.99 | 312.12388 | 312.12413 | 0.82 | C18H19NO4 | (+): 177 |
| 317 | 11.83 | Dryocrassin ABBA | 821.30122 | 821.30151 | 0.36 | 819.28569 | 819.28696 | 1.55 | C43H48O16 | (−): 611, 403 |
| 318 | 11.85 | Daidzein | 255.06551 | 255.06519 | −1.27 | 253.05027 | 253.05063 | 1.43 | C15H10O4 | (+): 227, 199 |
| 319 | 11.89 | Phillyrin | 557.20015 | 557.19933 | −1.47a | 579.20726 | 579.20831 | 1.83c | C27H34O11 | (+): 395, 373, 355, 337, 305 |
| 320 | 11.90 | Unknown | 745.32360 | 745.32319 | −0.55 | – | – | – | C43H44N4O8 | (+): 322, 219, 201, 189 |
| 321 | 11.91 | 4′-O-methyl glabridin isomer | 355.15397 | 355.15400 | 0.09 | – | – | – | C21H22O5 | (+): 337, 322, 306, 305, 290, 285, 284, 254 |
| 322 | 12.01 | Herbacetin | 303.05025 | 303.04993 | −1.06 | 301.03510 | 301.03538 | 0.92 | C15H10O7 | (−): 283 |
| 323 | 12.14 | Liquiritigenin | 257.08100 | 257.08084 | −0.65 | 255.06610 | 255.06628 | 0.72 | C15H12O4 | (+): 239, 211, 147, 137 |
| 324 | 12.15 | Lonijapospiroside A isomer | 562.19303 | 562.19190 | −2.01 | 560.17675 | 560.17735 | 1.08 | C27H31NO12 | (−): 296 |
| 325 | 12.20 | Chrysoeriol 7-O-glucoside | 463.12431 | 463.12349 | −1.78 | 461.10867 | 461.10894 | 0.57 | C22H22O11 | (−): 256 |
| 326 | 12.25 | Arctiin | 557.20005 | 557.19933 | −1.28a | 579.20736 | 579.20831 | 1.64c | C27H34O11 | (+): 395, 355, 337, 323, 305, 295, 277, 273, 263, 245, 237, 219 |
| 327 | 12.26 | Rhamnetin | 317.06599 | 317.06558 | −1.30 | 315.05155 | 315.05103 | −1.66 | C16H12O7 | (−): 300 |
| 328 | 12.38 | Eriodictyol | 289.07088 | 289.07066 | −0.75 | 287.05590 | 287.05611 | 0.73 | C15H12O6 | (+): 153 |
| 329 | 12.38 | Linarin | 593.18730 | 593.18648 | −1.39 | – | – | – | C28H32O14 | (+): 447, 285 |
| 330 | 12.50 | Chrysoeriol | 301.07091 | 301.07066 | −0.82 | 299.05600 | 299.05611 | 0.36 | C16H12O6 | (−): 284 |
| 331 | 12.50 | Sebacic acid | 203.12807 | 203.12779 | −1.40 | 201.11295 | 201.11323 | 1.41 | C10H18O4 | – |
| 332 | 12.55 | 1,6-Di-O-galloyl-2-O-cinnamoyl-β-D-glucose | – | – | – | 613.11880 | 613.11989 | 1.78 | C29H26O15 | (−): 461, 169 |
| 333 | 12.55 | Licorice saponin O4 | – | – | – | 1115.52753 | 1115.52798 | 0.40 | C54H84O24 | – |
| 334 | 12.65 | L-phenylalaninosecologanin B | 506.20241 | 506.20207 | −0.67 | 504.18704 | 504.18752 | 0.96 | C25H31NO10 | (−): 342, 324, 314, 272 |
| 335 | 12.70 | 1-O-Galloy1-6-O-cinnamoylglucose | – | – | – | 461.10906 | 461.10894 | −0.27 | C22H22O11 | (−): 313, 169 |
| 336 | 12.71 | Matairesinoside | – | – | – | 519.18734 | 519.18719 | −0.30 | C26H32O11 | (−): 357 |
| 337 | 12.75 | Erythro-dihydroguaiacylglycerol-O-4′-dehydrodisinapyl ether | – | – | – | 585.23417 | 585.23414 | −0.05 | C31H38O11 | – |
| 338 | 12.82 | Luteolind | 287.05523 | 287.05501 | −0.74 | 285.04038 | 285.04046 | 0.29 | C15H10O6 | (−): 268, 267, 243, 241, 239, 223, 217, 215, 213, 211, 201, 199, 197, 195, 185, 183, 175, 171, 151, 149, 133 |
| 339 | 12.84 | Kaempferin | 433.11331 | 433.11292 | −0.88 | 431.09817 | 431.09837 | 0.45 | C21H20O10 | (+): 287 |
| 340 | 12.87 | Sachalinoside A or isomer | 485.20051 | 485.20174 | 2.53 | 483.18711 | 483.18719 | 0.17 | C23H32O11 | – |
| 341 | 12.89 | Quercetin | 303.05017 | 303.04993 | −0.80 | 301.03529 | 301.03538 | 0.30 | C15H10O7 | (−): 151 |
| 342 | 12.90 | Kenposide A | – | – | – | 447.22336 | 447.22357 | 0.48 | C21H36O10 | – |
| 343 | 12.94 | Calycosin | 285.07596 | 285.07575 | −0.72 | 283.06112 | 283.06120 | 0.28 | C16H12O5 | (+): 270 |
| 344 | 13.07 | Rhamnoliquiritin | 565.19252 | 565.19157 | −1.68 | 563.17653 | 563.17701 | 0.86 | C27H32O13 | – |
| 345 | 13.08 | Rhodiooctanoside | 425.23899 | 425.23812 | −2.04 | 423.22330 | 423.22357 | 0.65 | C19H36O10 | (−): 291, |
| 346 | 13.10 | Torachrysone 8-O-glucoside | 409.14968 | 409.14931 | −0.91 | 407.13463 | 407.13476 | 0.32 | C20H24O9 | (−): 245 |
| 347 | 13.14 | Rhodioloside C | – | – | – | 493.22872 | 493.22905 | 0.67 | C22H38O12 | (−): 447 |
| 348 | 13.14 | Licorice glycoside E | 694.21415 | 694.21303 | −1.61 | 692.19904 | 692.19848 | −0.81 | C35H35NO14 | (−): 549, 531, 399, 255 |
| 349 | 13.16 | Chrysophanol-1-O-glucoside | 439.10043 | 439.09995 | −1.09a | 415.10322 | 415.10346 | 0.58 | C21H20O9 | (−): 253, 225 |
| 350 | 13.22 | Emodin-glucoside | 433.11268 | 433.11292 | 0.56 | 431.09808 | 431.09837 | 0.68 | C21H20O10 | (−): 269 |
| 351 | 13.33 | Ethyl caffeate | 209.08104 | 209.08084 | −0.96 | 207.06611 | 207.06628 | 0.85 | C11H12O4 | (−): 179, 161, 135 |
| 352 | 13.34 | Kaempferol-7-O-α-L-rhamnoside | 433.11357 | 433.11292 | −1.49 | 431.09799 | 431.09837 | 0.88 | C21H20O10 | (−): 285 |
| 353 | 13.37 | Myrciacitrin I | 479.15535 | 479.15479 | −1.17 | 477.14006 | 477.14024 | 0.36 | C23H26O11 | (−): 269 |
| 354 | 13.40 | Unknown | 590.26036 | 590.25959 | −1.32 | 588.24591 | 588.24503 | −1.49 | C30H39NO11 | (+): 428, 282 |
| 355 | 13.41 | Rhodioloside B | – | – | – | 493.22864 | 493.22905 | 0.83 | C22H38O12 | (−): 311 |
| 356 | 13.45 | Uralsaponin C isomer | 825.42822 | 825.42671 | −1.82 | 823.41124 | 823.41216 | 1.11 | C42H64O16 | (+): 455 |
| 357 | 13.53 | Pinoresinol | 359.14933 | 359.14891 | −1.15 | 357.13430 | 357.13436 | 0.17 | C20H22O6 | (−): 342, 151, 136 |
| 358 | 13.55 | Licoflavanone isomer | 341.13856 | 341.13835 | −0.63 | – | – | – | C20H20O5 | (+): 263 |
| 359 | 13.58 | Chrysophanol-8-O-glucoside | 439.10037 | 439.09995 | −0.96a | 415.10336 | 415.10346 | 0.23 | C21H20O9 | (−): 253, 225 |
| 360 | 13.66 | Wogonoside | 461.10819 | 461.10784 | −0.76 | 459.09377 | 459.09329 | −1.06 | C22H20O11 | (+): 285 |
| 361 | 13.81 | Di-O-galloyl-O-cinnamoyl-β-D-glucose | – | – | – | 613.11922 | 613.11989 | 1.09 | C29H26O15 | (−): 461, 169 |
| 362 | 13.81 | Licorice glycoside B | 697.21341 | 697.21270 | −1.02 | 695.19785 | 695.19814 | 0.43 | C35H36O15 | (−): 549, 531, 417, 399, 255 |
| 363 | 13.83 | Licorice glycoside A | 727.22367 | 727.22326 | −0.56 | 725.20767 | 725.20871 | 1.43 | C36H38O16 | (−): 255 |
| 364 | 13.88 | Neohesperidin dihydrochalcone | – | – | – | 611.19743 | 611.19814 | 1.16 | C28H36O15 | (−): 565 |
| 365 | 13.88 | 24-Hydroxy-licoricesaponin A3 | 1001.45919 | 1001.45880 | −0.39 | 999.44190 | 999.44425 | 2.34 | C48H72O22 | (+): 825, 649, 631, 487, 469, 451 |
| 366 | 13.91 | Laccaic acid D | 315.05015 | 315.04993 | −0.72 | 313.03522 | 313.03538 | 0.49 | C16H10O7 | (−): 269, 241, 225 |
| 367 | 13.99 | Erythro-guaiacylglycerol-O-4′-dehydrodisinapyl ether | 585.23441 | 585.23304 | −2.34 | 583.21807 | 583.21849 | 0.71 | C31H36O11 | (−): 535 |
| 368 | 14.14 | Di-O-galloyl-O-cinnamoyl-β-D-glucose | – | – | – | 613.11929 | 613.11989 | 0.98 | C29H26O15 | (−): 461 443, 169 |
| 369 | 14.14 | Syringlyglycerol-β-syringaresinol ether | – | – | – | 643.23901 | 643.23961 | 0.93 | C33H40O13 | (−): 595, 417, 387 |
| 370 | 14.37 | 24-Hydroxy-licoricesaponin A3 isomer | 1001.45939 | 1001.45880 | −0.58 | 999.44143 | 999.44425 | 2.82 | C48H72O22 | (−): 351 |
| 371 | 14.41 | Unknown | 685.24873 | 685.24908 | 0.52 | 729.23869 | 729.24001 | 1.81c | C35H40O14 | (−): 371, 149 |
| 372 | 14.50 | Uralsaponin F | 897.41308 | 897.41146 | −1.81 | 895.39620 | 895.39690 | 0.79 | C44H64O19 | (+): 545, 527 |
| 373 | 14.59 | Emodin-O-(6-carboxyacetyl)-β-D-glucopyranoside | 519.11381 | 519.11332 | −0.94 | 517.09827 | 517.09876 | 0.96 | C24H22O13 | (−): 269 |
| 374 | 14.60 | Uralsaponin T | 955.49216 | 955.48971 | −2.57 | 953.47433 | 953.47515 | 0.86 | C48H74O19 | (−): 351 |
| 375 | 14.67 | 22-Hydroxyl licorice saponin G2 | 855.40216 | 855.40089 | −1.48 | 853.38505 | 853.38634 | 1.51 | C42H62O18 | (+): 679, 661, 643, 503, 485, 467 |
| 376 | 14.75 | Erythro-guaiacylglycerol-O-4′-dehydrodisinapyl ether isomer | – | – | – | 583.21820 | 583.21849 | 0.48 | C31H36O11 | (−): 535 |
| 377 | 14.83 | 4,5-Dioxodehydroasimilobine | 294.07638 | 294.07608 | −1.02 | 292.06147 | 292.06153 | 0.21 | C17H11NO4 | – |
| 378 | 14.87 | Naringenin | 273.07596 | 273.07575 | −0.76 | 271.06109 | 271.06120 | 0.39 | C15H12O5 | (−): 177, 165, 151, 119, 107 |
| 379 | 15.02 | Amorfrutin 2 | 307.19061 | 307.19039 | −0.72 | 305.17575 | 305.17583 | 0.28 | C18H26O4 | (−): 261, 243, 191 |
| 380 | 15.05 | Prunetrin | – | – | – | 445.11408 | 445.11402 | −0.13 | C22H22O10 | (−): 283 |
| 381 | 15.06 | Echinatin | 271.09663 | 271.09649 | −0.55 | – | – | – | C16H14O4 | (+): 229, 177 |
| 382 | 15.08 | Glyzaglabrin | 299.05512 | 299.05501 | −0.35 | 297.04049 | 297.04046 | −0.11 | C16H10O6 | – |
| 383 | 15.08 | Uralsaponin F isomer | 897.41292 | 897.41146 | −1.63 | 895.39611 | 895.39690 | 0.88 | C44H64O19 | (−): 351 |
| 384 | 15.09 | Apigenind | 271.06023 | 271.06010 | −0.47 | 269.04547 | 269.04555 | 0.29 | C15H10O5 | (−): 237, 225, 201, 175, 151, 149 |
| 385 | 15.18 | Matairesinol | 359.14899 | 359.14891 | −0.21 | 357.13426 | 357.13436 | 0.27 | C20H22O6 | (+): 323, 305, 291 |
| 386 | 15.23 | Licorice saponin A3 | 985.46490 | 985.46389 | −1.03 | 983.44717 | 983.44933 | 2.20 | C48H72O21 | (−): 821 |
| 387 | 15.32 | Herbacetin-8-methyl ether | 317.06585 | 317.06558 | −0.87 | 315.05108 | 315.05103 | −0.17 | C16H12O7 | – |
| 388 | 15.37 | Uralsaponin D | 851.37053 | 851.36959 | −1.10 | 849.35583 | 849.35504 | −0.93 | C42H58O18 | (+): 499 |
| 389 | 15.39 | Matairesinol isomer | 359.14901 | 359.14891 | −0.26 | 357.13429 | 357.13436 | 0.21 | C20H22O6 | (−): 342 |
| 390 | 15.45 | Emodin-glucoside | 433.11357 | 433.11292 | −1.49 | 431.09831 | 431.09837 | 0.15 | C21H20O10 | (−): 269 |
| 391 | 15.47 | Genistein | 271.06031 | 271.06010 | −0.79 | 269.04562 | 269.04555 | −0.27 | C15H10O5 | (+): 243 |
| 392 | 15.56 | Kaempferol | 287.05511 | 287.05501 | −0.33 | 285.04045 | 285.04046 | 0.02 | C15H10O6 | (+): 269, 258, 241, 231, 213, 185, 165, 153 |
| 393 | 15.61 | Quercetin 3,4’-dimethyl ether or isomer | 331.08144 | 331.08123 | −0.63 | 329.06678 | 329.06668 | −0.32 | C17H14O7 | – |
| 394 | 15.63 | Emodin methyl ether-8-O-glucoside | 469.11082 | 469.11052 | −0.65a | 445.11405 | 445.11402 | −0.06 | C22H22O10 | (−): 283 |
| 395 | 15.66 | Physcion isomer | 285.07592 | 285.07575 | −0.60 | 283.06119 | 283.06120 | 0.03 | C16H12O5 | (−): 240 |
| 396 | 15.66 | 9,12-Dihydroxy-13-oxooctadec-14-enoic acid | 351.21417 | 351.21419 | 0.08a | 327.21741 | 327.21770 | 0.89 | C18H32O5 | (−): 229, 211, 183, 171 |
| 397 | 15.69 | Unknown | 543.19786 | 543.19732 | −1.00 | – | – | – | C27H31N2O10 | (+): 381, 363, 335, 311 |
| 398 | 15.75 | Kaempferide | 301.07102 | 301.07066 | −1.19 | 299.05633 | 299.05611 | −0.73 | C16H12O6 | (−): 284, 255, 240, 228 |
| 399 | 15.78 | 22-Hydroxyl licorice saponin G2 isomer | 855.40178 | 855.40089 | −1.03 | 853.38571 | 853.38634 | 0.73 | C42H62O18 | (−): 351 |
| 400 | 15.87 | Amorfrutin 2 isomer | 307.19056 | 307.19039 | −0.55 | 305.17585 | 305.17583 | −0.05 | C18H26O4 | (−): 261, 243, 191 |
| 401 | 15.87 | Uralsaponin R isomer | 971.48609 | 971.48462 | −1.52 | 969.46932 | 969.47007 | 0.77 | C48H74O20 | (+): 439 |
| 402 | 15.94 | 9,12-Dihydroxy-13-oxooctadec-14-enoic acid isomer | 351.21414 | 351.21419 | 0.15a | 327.21745 | 327.21770 | 0.77 | C18H32O5 | (−): 229, 211, 183, 171 |
| 403 | 16.06 | 22β-Acetoxylglycyrrhizin | 881.41716 | 881.41654 | −0.71 | 879.40042 | 879.40199 | 1.78 | C44H64O18 | (−): 351 |
| 404 | 16.13 | Isorhamnetin | 317.06551 | 317.06558 | 0.22 | 315.05089 | 315.05103 | 0.44 | C16H12O7 | (−): 300, 283, 271, 255, 243, 227, 151 |
| 405 | 16.17 | 24-Hydroxy-licorice-saponin E2 | 837.39098 | 837.39033 | −0.78 | 835.37446 | 835.37577 | 1.58 | C42H60O17 | (+): 485, 469, 467 |
| 406 | 16.18 | Uralsaponin X | 1027.47405 | 1027.47445 | 0.39 | 1025.45807 | 1025.45990 | 1.78 | C50H74O22 | – |
| 407 | 16.21 | Licorice saponin A3 isomer | 985.46418 | 985.46389 | −0.30 | 983.44730 | 983.44933 | 2.06 | C48H72O21 | (+): 647,453 |
| 408 | 16.35 | Uralsaponin R | 971.48605 | 971.48462 | −1.47 | 969.46925 | 969.47007 | 0.85 | C48H74O20 | (+): 439 |
| 409 | 16.37 | Yunganoside K2 | 839.40595 | 839.40598 | 0.03 | 837.39094 | 837.39142 | 0.58 | C42H62O17 | (−): 661, 485, 351 |
| 410 | 16.38 | Glabric acid isomer | 487.34218 | 487.34180 | −0.78 | – | – | – | C30H46O5 | (+): 469, 451 |
| 411 | 16.40 | Glabrolide | 469.33124 | 469.33124 | 0.00 | – | – | – | C30H44O4 | (+): 451 |
| 412 | 16.42 | Baicalein | 271.06018 | 271.06010 | −0.31 | 269.04562 | 269.04555 | −0.27 | C15H10O5 | (+): 253 |
| 413 | 16.49 | Dihydrolicorice saponin A3 isomer | 987.48093 | 987.47954 | −1.41 | 985.46372 | 985.46498 | 1.28 | C48H74O21 | (−): 823, 351 |
| 414 | 16.57 | Aristolactam AⅡ/F1 | 266.08121 | 266.08117 | −0.14 | 264.06661 | 264.06662 | 0.01 | C16H11NO3 | – |
| 415 | 16.68 | Licorice saponin B2 isomer | 809.43232 | 809.43180 | −0.65 | 807.41673 | 807.41724 | 0.64 | C42H64O15 | – |
| 416 | 16.72 | Uralsaponin R isomer | 971.48469 | 971.48462 | −0.07 | 969.46953 | 969.47007 | 0.55 | C48H74O20 | (+): 439 |
| 417 | 16.82 | Unknown | 349.20099 | 349.20095 | −0.11 | 347.18606 | 347.18640 | 0.97 | C20H28O5 | (−): 303, 285, 259, 243 |
| 418 | 16.94 | Licorice saponin A3 isomer | 985.46436 | 985.46389 | −0.48 | 983.44753 | 983.44933 | 1.83 | C48H72O21 | (+): 647, 453 |
| 419 | 16.98 | Glabrolide isomer | 469.33145 | 469.33124 | −0.45 | – | – | – | C30H44O4 | (+): 451 |
| 420 | 16.98 | Licorice saponin G2 isomer | 839.40663 | 839.40598 | −0.78 | 837.39080 | 837.39142 | 0.74 | C42H62O17 | (+): 487 |
| 421 | 17.03 | 22β-Acetoxyl Uralsaponin C | 867.43747 | 867.43728 | −0.22 | 865.42218 | 865.42272 | 0.63 | C44H66O17 | (+): 691 |
| 422 | 17.03 | Uralsaponin R isomer | 971.48596 | 971.48462 | −1.37 | 969.46968 | 969.47007 | 0.40 | C48H74O20 | (+): 439 |
| 423 | 17.12 | Uralsaponin Q | 941.47497 | 941.47406 | −0.97 | 939.45817 | 939.45950 | 1.41 | C47H72O19 | (+): 647, 471 |
| 424 | 17.14 | 9,12-Dihydroxy-13-oxooctadecanoic acid | 353.22983 | 353.22984 | 0.04a | 329.23309 | 329.23335 | 0.77 | C18H34O5 | (−): 311, 229, 211 |
| 425 | 17.17 | Uralsaponin T isomer | 955.49150 | 955.48971 | −1.88 | 953.47509 | 953.47515 | 0.07 | C48H74O19 | (−): 351 |
| 426 | 17.22 | Aristolactam AⅡ/F1 | 266.08131 | 266.08117 | −0.53 | 264.06657 | 264.06662 | 0.17 | C16H11NO3 | – |
| 427 | 17.46 | Isoliquiritigenin | 257.08088 | 257.08084 | −0.17 | 255.06616 | 255.06628 | 0.47 | C15H12O4 | (+): 239, 211, 147, 137 |
| 428 | 17.55 | Glyzaglabrin isomer | 299.05503 | 299.05501 | −0.07 | 297.04020 | 297.04046 | 0.87 | C16H10O6 | – |
| 429 | 17.62 | Bourneioside B | – | – | – | 957.50662 | 957.50645 | −0.17 | C48H78O19 | (−): 911, 791, 645, 603 |
| 430 | 17.71 | 22β-Acetoxyl Licorice saponin J2 | 883.43315 | 883.43219 | −1.09 | 881.41509 | 881.41764 | 2.89 | C44H66O18 | (+): 707 |
| 431 | 17.82 | Licorice saponin E2 | 821.39590 | 821.39541 | −0.59 | 819.37984 | 819.38086 | 1.24 | C42H60O16 | (+): 645, 469, 451 |
| 432 | 17.84 | Formononetin | 269.08085 | 269.08084 | −0.07 | 267.06619 | 267.06628 | 0.34 | C16H12O4 | (+): 254, 253, 237, 226, 225, 213, 197 |
| 433 | 17.92 | Glabrolide isomer | 469.33161 | 469.33124 | −0.80 | – | – | – | C30H44O4 | (+): 451 |
| 434 | 17.93 | Glabric acid | 487.34215 | 487.34180 | −0.73 | – | – | – | C30H46O5 | (+):469, 451 |
| 435 | 17.96 | Licorice saponin G2 | 839.40696 | 839.40598 | −1.17 | 837.39081 | 837.39142 | 0.73 | C42H62O17 | (+): 487, 469 |
| 436 | 17.97 | Norcepharadione B | 308.09206 | 308.09173 | −1.06 | – | – | – | C18H13NO4 | – |
| 437 | 18.04 | Phillygenin | 373.16478 | 373.16456 | −0.58 | 371.15018 | 371.15001 | −0.46 | C21H24O6 | (+): 355, 337, 306, 305, 284, 269 |
| 438 | 18.04 | Licorice saponin B2 isomer | – | – | – | 807.41600 | 807.41724 | 1.55 | C42H64O15 | – |
| 439 | 18.05 | Glycyuralin E | 371.14932 | 371.14891 | −1.09 | – | – | – | C21H22O6 | – |
| 440 | 18.05 | Uralsaponin O | 821.39785 | 821.39541 | −2.97 | 819.37964 | 819.38086 | 1.49 | C42H60O16 | (+): 645, 469, 451 |
| 441 | 18.06 | 4′-O-methyl glabridin | 355.15395 | 355.15400 | 0.15 | – | – | – | C21H22O5 | – |
| 442 | 18.12 | 10,16-Dihydroxy-palmitic acid | 289.23760 | 289.23734 | −0.91 | 287.22276 | 287.22278 | 0.07 | C16H32O4 | (−): 269, 241 |
| 443 | 18.23 | Clinodiside A or Bourneioside B | – | – | – | 957.50479 | 957.50645 | 1.74 | C48H78O19 | (−): 911 |
| 444 | 18.24 | Yunganoside J1/L1 isomer | 969.46673 | 969.46897 | 2.32 | 967.45147 | 967.45442 | 3.05 | C48H72O20 | (−): 803, 645, 497 |
| 445 | 18.30 | Amentoflavone | 539.09838 | 539.09727 | −2.05 | 537.08306 | 537.08272 | −0.63 | C30H18O10 | (−): 375 |
| 446 | 18.35 | Uralsaponin T isomer | 955.48929 | 955.48971 | 0.44 | 953.47373 | 953.47515 | 1.49 | C48H74O19 | (−): 351 |
| 447 | 18.38 | 22β-Acetoxyl-glycyrrhaldehyde | 887.40429 | 887.40357 | −0.81a | 863.40441 | 863.40707 | 3.09 | C44H64O17 | (+): 865, 689 |
| 448 | 18.49 | Yunganoside J1/L1 | 969.46957 | 969.46897 | −0.62 | 967.45405 | 967.45442 | 0.38 | C48H72O20 | (−): 803, 645, 497 |
| 449 | 18.56 | Glycyrrhizic acid isomer | 823.41153 | 823.41106 | −0.57 | 821.39558 | 821.39651 | 1.13 | C42H62O16 | (+): 647, 471 |
| 450 | 18.64 | Licorice saponin G2 isomer | 839.40623 | 839.40598 | −0.30 | 837.39103 | 837.39142 | 0.47 | C42H62O17 | (+): 487 |
| 451 | 18.64 | Licorice saponin A3 isomer | 985.46469 | 985.46389 | −0.81 | 983.44646 | 983.44933 | 2.92 | C48H72O21 | (−): 821 |
| 452 | 18.72 | 9,12-Dihydroxy-13-oxooctadecanoic acid isomer | 353.22977 | 353.22984 | 0.22a | 329.23323 | 329.23335 | 0.35 | C18H34O5 | (−): 311, 229, 211 |
| 453 | 18.78 | Uralsaponin T isomer | 955.49075 | 955.48971 | −1.09 | 953.47336 | 953.47515 | 1.88 | C48H74O19 | (−): 351 |
| 454 | 18.87 | Retusin | – | – | – | 357.09779 | 357.09798 | 0.51 | C19H18O7 | – |
| 455 | 18.88 | Aloe emodin | 271.06015 | 271.06010 | −0.20 | 269.04540 | 269.04555 | 0.54 | C15H10O5 | (−): 240, 223, 211 |
| 456 | 18.89 | Licorice saponin J2 isomer | 825.42742 | 825.42671 | −0.86 | 823.41107 | 823.41216 | 1.33 | C42H64O16 | (+): 455 |
| 457 | 19.00 | 9,12-Dihydroxy-13-oxooctadecanoic acid isomer | 353.22975 | 353.22984 | 0.27a | 329.23333 | 329.23335 | 0.06 | C18H34O5 | (−): 311, 229, 211 |
| 458 | 19.02 | Irisolidone | – | – | – | 313.07162 | 313.07176 | 0.46 | C17H14O6 | – |
| 459 | 19.06 | Dihydrolicorice saponin A3 isomer | 987.48014 | 987.47954 | −0.61 | 985.46561 | 985.46498 | −0.63 | C48H74O21 | (+): 629, 471, 453 |
| 460 | 19.11 | Norcepharadione B isomer | 308.09176 | 308.09173 | −0.09 | – | – | – | C18H13NO4 | – |
| 461 | 19.17 | Uralsaponin N | 839.40620 | 839.40598 | −0.26 | 837.39101 | 837.39142 | 0.49 | C42H62O17 | (+): 487 |
| 462 | 19.35 | Glycyrrhetic acid 3-O-glucuronide | 647.37926 | 647.37897 | −0.43 | – | – | – | C36H54O10 | (+): 453, 435, 407 |
| 463 | 19.49 | Glycyrrhizic acidd | 823.41127 | 823.41106 | −0.25 | 821.39607 | 821.39651 | 0.53 | C42H62O16 | (+): 647, 471, 453 |
| 464 | 19.57 | 22β-Acetoxyl-glycyrrhaldehyde isomer | 887.40351 | 887.40357 | 0.07a | 863.40508 | 863.40707 | 2.31 | C44H64O17 | (+): 865, 689 |
| 465 | 19.61 | Cepharadione B | 322.10739 | 322.10738 | −0.03 | – | – | – | C19H15NO4 | (+): 292 |
| 466 | 19.61 | Uralsaponin T isomer | 955.48943 | 955.48971 | 0.29 | 953.47476 | 953.47515 | 0.41 | C48H74O19 | (−): 351 |
| 467 | 19.65 | Licorice saponin B2 isomer | 809.43122 | 809.43180 | 0.71 | 807.41529 | 807.41724 | 2.42 | C42H64O15 | (+): 453 |
| 468 | 19.67 | Quercetin 3,4’-dimethyl ether or isomer | 331.08124 | 331.08123 | −0.02 | 329.06671 | 329.06668 | −0.09 | C17H14O7 | (−): 314, 299 |
| 469 | 19.68 | 9,12-Dihydroxy-13-oxooctadecanoic acid isomer | 353.22979 | 353.22984 | 0.15a | 329.23325 | 329.23335 | 0.29 | C18H34O5 | (−): 311, 229, 211 |
| 470 | 19.72 | Glycyrrhetinic acid rhamnosyl diglucuronide or isomer | 973.50145 | 973.50027 | −1.21 | – | – | – | C48H76O20 | (+): 471, 453 |
| 471 | 19.78 | Yunganoside J1/L1 isomer | 969.46972 | 969.46897 | −0.77 | 967.45159 | 967.45442 | 2.93 | C48H72O20 | (−): 803, 645, 497 |
| 472 | 19.82 | Dihydrolicorice saponin A3 isomer | 987.48065 | 987.47954 | −1.13 | 985.46146 | 985.46498 | 3.58 | C48H74O21 | (+): 629, 471, 453 |
| 473 | 19.91 | Rhein | 285.03941 | 285.03936 | −0.17 | 283.02465 | 283.02481 | 0.55 | C15H8O6 | (−): 255, 239, 211, 183 |
| 474 | 19.92 | Antrapurol | – | – | – | 239.03490 | 239.03498 | 0.34 | C14H8O4 | (−): 211 |
| 475 | 19.95 | Licorice saponin B2 isomer | 809.43191 | 809.43180 | −0.14 | 807.41581 | 807.41724 | 1.78 | C42H64O15 | (−): 631, 351 |
| 476 | 19.97 | Glycyrrhetinic acid monoglucuronide or isomer | 647.37929 | 647.37897 | −0.48 | – | – | – | C36H54O10 | (+): 453, 435, 407 |
| 477 | 20.06 | Unknown | – | – | – | 607.18122 | 607.18210 | 1.46 | C32H32O12 | (−): 443 |
| 478 | 20.14 | Echinatin isomer | 271.09652 | 271.09649 | −0.13 | – | – | – | C16H14O4 | (+): 239 |
| 479 | 20.18 | Uralsaponin O isomer | 821.39595 | 821.39541 | −0.66 | 819.37883 | 819.38086 | 2.47 | C42H60O16 | (+): 469 |
| 480 | 20.23 | Licorice saponin G2 isomer | 839.40665 | 839.40598 | −0.80 | 837.39002 | 837.39142 | 1.67 | C42H62O17 | (+): 487 |
| 481 | 20.34 | Licorice saponin B2 | 809.43231 | 809.43180 | −0.64 | 807.41544 | 807.41724 | 2.23 | C42H64O15 | (−): 631, 455, 351 |
| 482 | 20.34 | Licorice saponin J2 isomer | 825.42845 | 825.42671 | −2.11 | 823.41058 | 823.41216 | 1.92 | C42H64O16 | (+): 487, 469 |
| 483 | 20.37 | Uralsaponin R isomer | 971.48545 | 971.48462 | −0.86 | 969.46829 | 969.47007 | 1.84 | C48H74O20 | (−): 497 |
| 484 | 20.41 | Yunganoside J1/L1 | 969.47038 | 969.46897 | −1.45 | 967.45266 | 967.45442 | 1.82 | C48H72O20 | (−): 803, 645, 497 |
| 485 | 20.42 | Wogonin | 285.07579 | 285.07575 | −0.14 | 283.06112 | 283.06120 | 0.28 | C16H12O5 | (+): 270 |
| 486 | 20.42 | Yunganoside A1 | 957.50618 | 957.50536 | −0.86 | 955.48997 | 955.49080 | 0.87 | C48H76O19 | (+): 811 |
| 487 | 20.46 | Uralsaponin T isomer | 955.49226 | 955.48971 | −2.67 | 953.47267 | 953.47515 | 2.60 | C48H74O19 | (−): 351 |
| 488 | 20.63 | 9,12-Dihydroxy-13-oxooctadecanoic acid isomer | 353.22973 | 353.22984 | 0.32a | 329.23317 | 329.23335 | 0.55 | C18H34O5 | (−): 311, 229, 211 |
| 489 | 20.72 | Glycyrrhetinic acid monoglucuronide or isomer | 647.37932 | 647.37897 | −0.53 | – | – | – | C36H54O10 | (+): 453, 435, 407 |
| 490 | 20.74 | Chrysin | 255.06551 | 255.06519 | −1.27 | 253.05084 | 253.05063 | −0.81 | C15H10O4 | (−): 209 |
| 491 | 20.77 | Licorice saponin H2 | 823.41114 | 823.41106 | −0.10 | 821.39529 | 821.39651 | 1.48 | C42H62O16 | (+): 647, 471 |
| 492 | 20.85 | Uralsaponin T isomer | – | – | – | 953.47421 | 953.47515 | 0.99 | C48H74O19 | (−): 351 |
| 493 | 20.98 | Yunganoside B1 | 957.50595 | 957.50536 | −0.62 | 955.48940 | 955.49080 | 1.47 | C48H76O19 | (+): 811 |
| 494 | 21.21 | Licorice saponin B2 isomer | 809.43122 | 809.43180 | 0.71 | 807.41612 | 807.41724 | 1.39 | C42H64O15 | (−): 351 |
| 495 | 21.29 | Cepharanone B | 280.09680 | 280.09682 | 0.05 | – | – | – | C17H13NO3 | (+): 265 |
| 496 | 21.30 | Licroice saponin K2 | 823.41144 | 823.41106 | −0.45 | 821.39556 | 821.39651 | 1.16 | C42H62O16 | (+): 647, 471 |
| 497 | 21.44 | Uralsaponin Q isomer | 941.47414 | 941.47406 | −0.09 | 939.45792 | 939.45950 | 1.69 | C47H72O19 | (+): 647, 471 |
| 498 | 21.45 | Oroxylin A | 285.07578 | 285.07575 | −0.12 | 283.06102 | 283.06120 | 0.62 | C16H12O5 | (+): 270 |
| 499 | 21.49 | Clinodiside A | – | – | – | 957.50566 | 957.50645 | 0.83 | C48H78O19 | (−): 911, 749, 471 |
| 500 | 21.51 | 3-O-rhamnopyranosyl-(2→1)-arabinopyranosyl-28-O-glucopyranosyl hederagenin | 913.51412 | 913.51553 | 1.54 | 911.49761 | 911.50097 | 3.69 | C47H76O17 | (−): 749, 603, 471 |
| 501 | 21.54 | Licorice saponin B2 isomer | – | – | – | 807.41490 | 807.41724 | 2.91 | C42H64O15 | (−): 351 |
| 502 | 21.71 | Licorice saponin J2 | 825.42726 | 825.42671 | −0.66 | 823.41044 | 823.41216 | 2.09 | C42H64O16 | (+): 455, 437 |
| 503 | 21.77 | Glycyrrhetinic acid monoglucuronide or isomer | 647.37922 | 647.37897 | −0.37 | – | – | – | C36H54O10 | (+): 453, 435, 407 |
| 504 | 21.77 | Araboglycyrrhizin | 779.42277 | 779.42123 | −1.97 | 777.40466 | 777.40668 | 2.60 | C41H62O14 | (+): 453 |
| 505 | 21.81 | Sophoraisoflavone A | 353.10190 | 353.10196 | 0.19 | 351.08794 | 351.08741 | −1.51 | C20H16O6 | (+): 311 |
| 506 | 21.85 | Licoflavonol | 355.11802 | 355.11761 | −1.14 | 353.10281 | 353.10306 | 0.70 | C20H18O6 | (−): 297 |
| 507 | 21.88 | Diosmetin | – | – | – | 299.05591 | 299.05611 | 0.67 | C16H12O6 | (−): 284, 256 |
| 508 | 21.89 | Uralsaponin B | 823.41119 | 823.41106 | −0.16 | 821.39391 | 821.39651 | 3.17 | C42H62O16 | (+): 647, 471 |
| 509 | 21.99 | Uralsaponin T isomer | – | – | – | 953.47362 | 953.47515 | 1.61 | C48H74O19 | (−): 351 |
| 510 | 22.13 | Dimethoxyluteolin | 315.08630 | 315.08631 | 0.04 | 313.07152 | 313.07176 | 0.77 | C17H14O6 | (+): 300 |
| 511 | 22.39 | Glycyrrhisoflavone | 355.11757 | 355.11761 | 0.12 | 353.10276 | 353.10306 | 0.85 | C20H18O6 | (−): 297 |
| 512 | 22.45 | Uralsaponin T isomer | 955.48924 | 955.48971 | 0.48 | 953.47302 | 953.47515 | 2.23 | C48H74O19 | (−): 351 |
| 513 | 22.49 | Cepharadione B isomer | 322.10738 | 322.10738 | 0.00 | – | – | – | C19H15NO4 | – |
| 514 | 22.50 | Uralsaponin C | 825.42680 | 825.42671 | −0.11 | 823.41054 | 823.41216 | 1.97 | C42H64O16 | (+): 455, 437 |
| 515 | 22.53 | Glicophenone | 359.14901 | 359.14891 | −0.26 | 357.13414 | 357.13436 | 0.63 | C20H22O6 | – |
| 516 | 22.61 | Licorice saponin C2 | 829.39863 | 829.39809 | −0.65a | 805.39991 | 805.40159 | 2.09 | C42H62O15 | (−): 351 |
| 517 | 22.64 | Glycycoumarin | 369.13218 | 369.13326 | 2.93 | 367.11839 | 367.11871 | 0.89 | C21H20O6 | (+): 313, 285 |
| 518 | 22.66 | Carnosic acid isomer | 333.20665 | 333.20604 | −1.83 | 331.19192 | 331.19148 | −1.32 | C20H28O4 | (−): 287, 271 |
| 519 | 22.73 | Licofuranone | 357.13365 | 357.13326 | −1.09 | 355.11903 | 355.11871 | −0.90 | C20H20O6 | (−): 229, 193 |
| 520 | 22.92 | Saikosaponin B2/D | – | – | – | 779.45667 | 779.45872 | 2.62 | C42H68O13 | – |
| 521 | 22.92 | Uralsaponin W | 807.41648 | 807.41615 | −0.41 | 805.39962 | 805.40159 | 2.46 | C42H62O15 | (−): 351 |
| 522 | 22.98 | 5,3′-Dimethoxyluteolin | 315.08622 | 315.08631 | 0.29 | 313.07146 | 313.07176 | 0.97 | C17H14O6 | (−): 298, 283, 255 |
| 523 | 23.08 | Glyasperin C | 357.16961 | 357.16965 | 0.13 | 355.15478 | 355.15510 | 0.88 | C21H24O5 | – |
| 524 | 23.09 | Semilicoisoflavone B | 353.10185 | 353.10196 | 0.33 | 351.08708 | 351.08741 | 0.93 | C20H16O6 | (+): 311 |
| 525 | 23.10 | Licorice saponin B2 isomer | – | – | – | 807.41423 | 807.41724 | 3.73 | C42H64O15 | (−): 351 |
| 526 | 23.14 | Licoflavanone | 341.13841 | 341.13835 | −0.18 | 339.12347 | 339.12380 | 0.98 | C20H20O5 | (−): 293, 229, 167 |
| 527 | 23.24 | Arjunolic acid | 489.35780 | 489.35745 | −0.71 | 487.34247 | 487.34290 | 0.87 | C30H48O5 | (−): 409 |
| 528 | 23.28 | Uralenin | 355.11742 | 355.11761 | 0.55 | 353.10281 | 353.10306 | 0.72 | C20H18O6 | – |
| 529 | 23.32 | 9-Hydroxy-12-oxo-10-octadecenoic acid | 313.23724 | 313.23734 | 0.31 | 311.22251 | 311.22278 | 0.87 | C18H32O4 | (−): 293, 275 |
| 530 | 23.32 | Licorice saponin B2 isomer | 809.43218 | 809.43180 | −0.48 | 807.41475 | 807.41724 | 3.09 | C42H64O15 | (−): 351 |
| 531 | 23.34 | Glabrene | – | – | – | 321.11278 | 321.11323 | 1.41 | C20H18O4 | – |
| 532 | 23.42 | Yunganoside C1 | 957.50565 | 957.50536 | −0.31 | 955.48971 | 955.49080 | 1.14 | C48H76O19 | (+): 811 |
| 533 | 23.43 | Uralsaponin R isomer | 971.48496 | 971.48462 | −0.35 | 969.46870 | 969.47007 | 1.41 | C48H74O20 | (−): 497 |
| 534 | 23.49 | Glycyrrhizic acid isomer | 823.41117 | 823.41106 | −0.13 | 821.39408 | 821.39651 | 2.96 | C42H62O16 | (+): 647, 471 |
| 535 | 23.60 | Pachypodol | 345.09691 | 345.09688 | −0.08 | 343.08208 | 343.08233 | 0.71 | C18H16O7 | (−): 328, 313, 285, 270, 257, 242 |
| 536 | 23.77 | Gancaonin L | 355.11757 | 355.11761 | 0.13 | 353.10273 | 353.10306 | 0.93 | C20H18O6 | (+): 299, 287 |
| 537 | 23.88 | Hederagenin-3-O-α-L-rhamnopyranosyl-(1→2)-α-L-arabinopyranoside | – | – | – | 795.45219 | 795.45363 | 1.81c | C41H66O12 | (−): 749 |
| 538 | 23.89 | Carnosic acid | 333.20618 | 333.20604 | −0.42 | 331.19121 | 331.19148 | 0.82 | C20H28O4 | (−): 287, 271 |
| 539 | 23.93 | Licochalcone D | 355.15398 | 355.15400 | 0.06 | 353.13919 | 353.13945 | 0.72 | C21H22O5 | (−): 338 |
| 540 | 23.99 | 8-O-Methylretusin | 299.09190 | 299.09140 | −1.66 | – | – | – | C17H14O5 | – |
| 541 | 24.17 | Licorice saponin J2 isomer | 825.42689 | 825.42671 | −0.21 | 823.41084 | 823.41216 | 1.60 | C42H64O16 | (+): 455, 437 |
| 542 | 24.27 | (2R,3R)-3,4′,7-Trihydroxy-3′-prenylflavane | 341.13882 | 341.13835 | −1.37 | 339.12441 | 339.12380 | −1.81 | C20H20O5 | – |
| 543 | 24.30 | Unknown | 363.21646 | 363.21660 | 0.40 | 361.20146 | 361.20205 | 1.62 | C21H30O5 | (−): 317, 285 |
| 544 | 24.35 | Curdione | 237.18481 | 237.18491 | 0.41 | – | – | – | C15H24O2 | (+): 219, 135 |
| 545 | 24.35 | Unknown | 495.34449 | 495.34420 | −0.59 | – | – | – | C28H42N6O2 | (+):259 |
| 546 | 24.50 | Licoisoflavone A | 355.11750 | 355.11761 | 0.34 | 353.10271 | 353.10306 | 1.00 | C20H18O6 | (−): 309, 285, 267, 243 |
| 547 | 24.63 | Glycyrin | 405.13090 | 405.13086 | −0.10a | 381.13413 | 381.13436 | 0.60 | C22H22O6 | (−): 366, 351 |
| 548 | 24.68 | Aurantiamide acetate | 445.21207 | 445.21218 | 0.26 | 443.19719 | 443.19763 | 0.99 | C27H28N2O4 | (+): 224, 194 |
| 549 | 24.79 | Morachalcone A | 341.13887 | 341.13835 | −1.53 | 339.12457 | 339.12380 | −2.26 | C20H20O5 | – |
| 550 | 24.79 | Licorice saponin C2 isomer | 829.39856 | 829.39809 | −0.56a | 805.40103 | 805.40159 | 0.70 | C42H62O15 | (−): 351 |
| 551 | 24.81 | Licochalcone A | 339.15934 | 339.15909 | −0.75 | 337.14423 | 337.14453 | 0.90 | C21H22O4 | (+): 297, 283, 271, 245, 229, 219 |
| 552 | 24.82 | Glycyrrhetinic acid monoglucuronide or isomer | 647.37921 | 647.37897 | −0.36 | 645.36308 | 645.36442 | 2.08 | C36H54O10 | (+): 453, 435, 407 |
| 553 | 24.87 | Licoflavone A | – | – | – | 321.11396 | 321.11323 | −2.28 | C20H18O4 | – |
| 554 | 24.89 | Uralsaponin T | – | – | – | 953.47459 | 953.47515 | 0.60 | C48H74O19 | (−): 351 |
| 555 | 25.07 | Octadecanedioic acid or isomer | 337.23488 | 337.23493 | 0.14a | 313.23807 | 313.23843 | 1.15 | C18H34O4 | (−): 295, 277 |
| 556 | 25.08 | Emodin | 271.06011 | 271.06010 | −0.03 | 269.04543 | 269.04555 | 0.44 | C15H10O5 | (−): 241, 225, 210 |
| 557 | 25.26 | Licorice saponin B2 isomer | – | – | – | 807.41556 | 807.41724 | 2.08 | C42H64O15 | – |
| 558 | 25.27 | Neoglycyrol | 367.11745 | 367.11761 | 0.45 | 365.10281 | 365.10306 | 0.70 | C21H18O6 | (+): 339, 311, 296, 283 |
| 559 | 25.34 | Octadecanedioic acid or isomer | 337.23492 | 337.23493 | 0.02a | 313.23823 | 313.23843 | 0.66 | C18H34O4 | (−): 295 |
| 560 | 25.58 | Psoralidin or isomer | 337.10695 | 337.10705 | 0.30 | 335.09234 | 335.09250 | 0.46 | C20H16O5 | (−): 320, 307, 291, 213 |
| 561 | 25.69 | Glabridin | 325.14310 | 325.14344 | 1.03 | 323.12963 | 323.12888 | −2.30 | C20H20O4 | (−): 305, 279, 253, 213, 201, 187, 175, 147, 135 |
| 562 | 26.00 | Kaurenoic acid | 303.23181 | 303.23186 | 0.17 | – | – | – | C20H30O2 | (+): 257 |
| 563 | 26.07 | Hydroxyglycyrrhetic acid | 487.34173 | 487.34180 | 0.14 | 485.32685 | 485.32725 | 0.82 | C30H46O5 | – |
| 564 | 26.32 | Licoisoflavone B | 353.10197 | 353.10196 | −0.03 | 351.08720 | 351.08741 | 0.61 | C20H16O6 | (+): 311 |
| 565 | 26.40 | Pogostone | 225.11206 | 225.11214 | 0.32 | 223.09741 | 223.09758 | 0.79 | C12H16O4 | (−): 139 |
| 566 | 26.62 | Gingerglycolipid B | – | – | – | 723.38016 | 723.38086 | 0.96c | C33H58O14 | (−): 677 |
| 567 | 26.87 | Glabrone | 337.10749 | 337.10705 | −1.31 | 335.09239 | 335.09250 | 0.32 | C20H16O5 | (−): 320, 307, 291 |
| 568 | 26.95 | Hispaglabridin A | 393.20685 | 393.20604 | −2.08 | 391.19232 | 391.19148 | −2.13 | C25H28O4 | – |
| 569 | 27.08 | Glyasperin D | 371.18533 | 371.18530 | −0.07 | 369.17051 | 369.17075 | 0.64 | C22H26O5 | (+): 303 |
| 570 | 27.20 | Manglupenone or isomer | 437.34145 | 437.34141 | −0.11 | – | – | – | C30H44O2 | (+): 391 |
| 571 | 27.39 | Gancaonin E | 425.19602 | 425.19587 | −0.36 | 423.18112 | 423.18131 | 0.46 | C25H28O6 | (−): 229, 193 |
| 572 | 27.41 | Chrysophanol | 255.06528 | 255.06519 | −0.39 | 253.05052 | 253.05063 | 0.46 | C15H10O4 | (−): 225, 210, 197, 182, 181 |
| 573 | 27.46 | Hederagenin | 473.36332 | 473.36254 | −1.66 | 471.34753 | 471.34798 | 0.96 | C30H48O4 | (+): 409, 391 |
| 574 | 27.62 | 3-Hydroxyglabrol | 409.20072 | 409.20095 | 0.56 | 407.18743 | 407.18640 | −2.55 | C25H28O5 | (−): 219 |
| 575 | 27.64 | 9S-Hyroxy-10E,12E-octadecadienoic acid | 297.24268 | 297.24242 | −0.87 | 295.22816 | 295.22787 | −1.00 | C18H32O3 | (−): 277, 227, 195, 183, 155, 139 |
| 576 | 27.78 | Gancaonin E isomer | 425.19688 | 425.19587 | −2.39 | 423.18199 | 423.18131 | −1.60 | C25H28O6 | (−): 229, 193 |
| 577 | 27.79 | Angustone A | 423.18105 | 423.18022 | −1.97 | 421.16658 | 421.16566 | −2.18 | C25H26O6 | (−): 309 |
| 578 | 27.93 | Isoangustone A | 423.18111 | 423.18022 | −2.13 | 421.16644 | 421.16566 | −1.84 | C25H26O6 | (−): 309 |
| 579 | 27.93 | Glycyrrhetinic acid isomer | 471.34746 | 471.34689 | −1.22 | 469.33234 | 469.33233 | −0.01 | C30H46O4 | (+): 425, 407 |
| 580 | 28.17 | Corosolic acid | 473.36226 | 473.36254 | 0.58 | 471.34761 | 471.34798 | 0.79 | C30H48O4 | (+): 437, 409, 313, 205 |
| 581 | 28.40 | Glyasperin A | 423.18121 | 423.18022 | −2.35 | 421.16610 | 421.16566 | −1.04 | C25H26O6 | (−): 379 |
| 582 | 28.40 | Physcion | 285.07586 | 285.07575 | −0.40 | 283.06098 | 283.06120 | 0.75 | C16H12O5 | (−): 269, 268, 240 |
| 583 | 28.49 | Lupenone isomer | 425.37876 | 425.37779 | −2.27 | – | – | – | C30H48O | – |
| 584 | 28.55 | Glyinflanin C | 407.18612 | 407.18530 | −2.01 | 405.17115 | 405.17075 | −0.99 | C25H26O5 | (−): 201 |
| 585 | 28.72 | Unknown | 495.33188 | 495.33163 | −0.50 | 493.31625 | 493.31708 | 1.67 | C28H46O7 | (+): 477, 459, 441, 431, 413, 399 |
| 586 | 28.79 | Glycyrrhetinic acidd | 471.34712 | 471.34689 | −0.49 | 469.33310 | 469.33233 | −1.64 | C30H46O4 | (+): 453, 435, 425, 407, 389 |
| 587 | 28.86 | Lupenone | 425.37879 | 425.37779 | −2.33 | – | – | – | C30H48O | – |
| 588 | 28.96 | Unknown | 495.33199 | 495.33163 | −0.73 | 493.31616 | 493.31708 | 1.85 | C28H46O7 | (−): 475 |
| 589 | 29.82 | Flavaspidic acid AB | – | – | – | 417.15542 | 417.15549 | 0.16 | C22H26O8 | (−): 221, 209, 207, 195 |
| 590 | 29.98 | γ-Linolenic acid | 279.23235 | 279.23186 | −1.75 | 277.21689 | 277.21730 | 1.48 | C18H30O2 | (−): 233 |
| 591 | 30.23 | Ursolic acid | – | – | – | 455.35247 | 455.35307 | 1.32 | C30H48O3 | (−): 407 |
| 592 | 30.45 | Betulinic acid | 457.36796 | 457.36762 | −0.74 | 455.35241 | 455.35307 | 1.45 | C30H48O3 | (−): 407, 391 |
| 593 | 30.71 | Linoleic acid | – | – | – | 279.23247 | 279.23295 | 1.73 | C18H32O2 | (−): 261 |
| 594 | 30.93 | Oleanolic acid | 457.36747 | 457.36762 | 0.33 | 455.35223 | 455.35307 | 1.84 | C30H48O3 | (−): 407, 391 |
| 595 | 31.42 | Hexadecanoic acid | – | – | – | 255.23269 | 255.23295 | 1.05 | C16H32O2 | (−): 237 |
| 596 | 31.62 | Oleic acid | – | – | – | 281.24818 | 281.24860 | 1.52 | C18H34O2 | – |
—: not detected.
[M+Na]+.
[M + NH4]+.
[M + HCOO]-.
Compared with a reference standard.
3.1.1. Flavonoids
Flavonoids, for example, isoliquiritigenin possesses effectiveness of anti-inflammatory [31]. Flavonoids in Lianhua Qingwen capsule mainly include flavones, isoflavones, flavonols, flavanones, chalcones, and isoflavans.
The identifications of rutin and kaempferol were taking as the examples of flavonols for illustration. Compound 199 with a retention time of 7.81 min generated the precursor ion of [M+H]+ at m/z 611.16097, indicating the molecular formula of C27H30O16. The characteristic fragments m/z 465.10267 and m/z 303.04947 corresponding to fragment ions [M + H-Rha (Rhamnosyl group, C6H10O4)]+ and [M + H-Rha-Glc (Glucosyl group, C6H10O5)]+ were observed. were observed. It was putatively characterized as rutin. Compound 392 with a retention time of 15.56 min generated the precursor ion of [M+H]+ at m/z 287.05511 in positive ion mode, indicating the molecular formula of C15H10O6. The characteristic fragments at m/z 269.04370, m/z 258.05152, m/z 241.04887, m/z 231.06472, m/z 213.05426 m/z 185.05875, m/z 165.01764, and m/z 153.01757 corresponded to [M + H–H2O]+, [M + H–CHO]+, [M + H–H2O–CO]+, [M + H–2CO]+, [M + H–2CO–H2O]+, [M + H–3CO–H2O]+, [M + H–C7H6O2]+, and [M + H–C8H6O2]+. It was putatively characterized as kaempferol.
The identifications of isoviolanthin and luteolin were taking as the examples of flavones for illustration. Compound 197 with a retention time of 7.76 min generated the precursor ion of [M − H]- at m/z 577.15506, indicating the molecular formula of C27H30O14. The fragments at m/z 457.11433 [M-H-120]-, m/z 439.10370 [M-H-120-18]-, m/z 413.08700, [M-H-164]- m/z 395.07664 [M-H-164-18]-, m/z 383.07676 [M-H-194]-, m/z 365.06635 [M-H-194-18]-, m/z 353.06635 [M-H-224]-, m/z 337.07184 [M-H-194-18-28]-, m/z 325.07209 [M-H-224-28]-, m/z 311.05522 [M-H-266]- and m/z 297.07643 [M-H-224-56]- corresponded to [M-H-C4H8O4]-, [M-H–C4H8O4–H2O]-, [M-H-C6H12O5]-, [M-H–C6H12O5–H2O]-, [M-H-C7H14O6]-, [M-H–C7H14O6–H2O]-, [M-H-C8H16O7]-, [M-H–C7H14O6–H2O–CO]-, [M-H–C8H16O7–CO]-, [M-H-C10H18O8]-, and [M-H–C8H16O7–2CO]-. It was putatively characterized as isoviolanthin. Compound 338 with a retention time of 12.82 min generated the precursor ion of [M − H]- at m/z 285.04038, indicating the molecular formula of C15H10O6. The fragments at m/z 268.03756, m/z 267.02963, m/z 243.02957, m/z 241.05043, m/z 239.03480, m/z 223.03996, m/z 217.05046, m/z 215.03451, m/z 213.05547, m/z 211.03995, m/z 201.01930, m/z 199.03991, m/z 197.06068, m/z 195.04506, m/z 185.06059, m/z 183.04495, m/z 175.03994, m/z 171.04510, m/z 151.00357, m/z 149.02429 and m/z 133.02935 corresponded to [M-H-OH]-, [M-H-H2O]-, [M-H-C2H2O]-, [M-H-CO2]-, [M-H-CH2O2]-, [M-H-CH2O3]-, [M-H-C3O2]-, [M-H-C3H2O2]-, [M-H-C2O3]-, [M-H-C2H2O3]-, [M-H-C4H4O2]-, [M-H-C3H2O3]-, [M-H-C2O4]-, [M-H-C2H2O4]-, [M-H-C3O4]-, [M-H-C3H2O4]-, [M-H-C5H2O3]-, [M-H-C4H2O4]-, [M-H-C8H6O2]-, [M-H-C7H4O3]-, and [M-H-C7H4O4]-. It was identified as luteolin.
The identifications of ononin and formononetin were taking as the examples of isoflavones for illustration. Compound 301 with a retention time of 11.06 min generated the precursor ion of [M+H]+ at m/z 431.13390, indicating the molecular formula of C22H22O9. The fragment ion at m/z 269.08043 [M + H-glucose]+ was observed. It was putatively characterized as ononin. Compound 432 with a retention time of 17.84 min generated the precursor ion of [M+H]+ at m/z 269.08085 in positive ion mode, indicating the formation of C16H12O4. The characteristic fragments at m/z 254.05685, m/z 253.04903, m/z 237.05400, m/z 226.06187, m/z 225.05375, m/z 213.09037, and m/z 197.05929 corresponded to [M + H–CH3]+, [M + H–CH4]+, [M + H–CH4O]+, [M + H–C2H3O]+, [M + H–C2H4O]+, [M + H–2CO]+, and [M + H–C3H4O2]+. It was putatively characterized as formononetin.
The identifications of liquiritigenin, licorice glycoside B and naringenin were taking as the examples of flavanones, and isoliquiritigenin, licorice glycoside D1/D2, echinatin, and licochalcone A were taking as the examples of chalcones for illustration. Chalcones possess an open and unsaturated 3-C chain rather than a heterocycle C. Chalcones with C-2′-OH such as isoliquiritigenin, licorice glycoside D1/D2, and the corresponding flavanone such as liquiritigenin, licorice glycoside B were isomers, have quite similar MS/MS fragment ions, and it is arduous to distinguish one from the other by means of MS/MS data. But retention time will also provide a reference for identifying compounds.
Compound 427 (tR = 17.46 min) showed deprotonated ion [M+H]+ at m/z 257.08088, corresponding to a molecular formula of C15H12O4. In the MS2 spectrum, the characteristic fragments at m/z 239.06994, m/z 211.07504, m/z 147.04390 and m/z 137.02309 corresponded to [M + H–H2O]+, [M + H–CO–H2O]+, [M + H–C6H6O2]+ and [M + H–C8H8O]+. The product ion at m/z 137.02309 was generated through RDA cleavage. It was identified as isoliquiritigenin. Compound 323 (tR = 12.14 min) showed deprotonated ion [M+H]+ at m/z 257.08100, with similar fragment behaviors to that of isoliquiritigenin. It was identified as liquiritigenin. Compound 311 (tR = 11.63 min) showed deprotonated ion [M − H]- at m/z 695.19746, corresponding to a molecular formula of C35H36O15. In the MS2 spectrum, the characteristic fragments at m/z 549.16094, m/z 531.15018, m/z 417.11811, m/z 399.10799 and m/z 255.06610 corresponded to [M-H-C9H6O2]-, [M-H–C9H6O2–H2O]-, [M-H–C9H6O2–Api (Apiosyl group, C5H8O4)]-, [M-H–C9H6O2–Api-H2O]-, and [M-H–C9H6O2–Api-Glc]-. It was temporarily deduced as licorice glycoside D1/D2. And the MS/MS spectrum is shown in Fig. 3. Compound 362 (tR = 13.81 min) showed deprotonated ion [M − H]- at m/z 695.19785, with similar fragment behaviors to that of licorice glycoside D1/D2. It was temporarily deduced as licorice glycoside B.
Fig. 3.
The MS/MS spectrum of licorice glycoside D1/D2.
Compound 378 with a retention time of 14.87 min generated the precursor ion of [M − H]- at m/z 271.06109, indicating the molecular formula of C15H12O5. The characteristic fragments at m/z 177.01922, m/z 165.01934, m/z 151.00363, m/z 119.05013, and m/z 107.01387 corresponded to [M-H-C6H6O]-, [M-H-C7H6O]-, [M-H-C8H8O]-, [M-H-C7H4O4]-, and [M-H-C9H8O3]-. The precursor ion underwent RDA cleavage, resulted in two complementary product ions at m/z 151.00363 and m/z 119.05013. It was putatively characterized as naringenin.
The precursor ion [M+H]+ of compound 381 at m/z 271.09663 was observed at 15.06 min. The molecular formula was C16H14O4, as predicted by the precursor ion. In the MS/MS spectrum, the fragment ions were at m/z 229.08556 and m/z 177.05436 corresponded to [M + H–C2H2O]+ and [M + H–C6H6O]+. The compound was putatively characterized as echinatin. The precursor ion [M+H]+ of compound 551 at m/z 339.15934 was observed at 24.81 min. The molecular formula was C21H22O4, as predicted by the precursor ion. In the MS2 spectrum, the fragment ions were at m/z 297.14808, m/z 283.09523, m/z 271.09615, m/z 245.11679, m/z 229.08549, and m/z 219.10075 corresponded to [M + H–C2H2O]+, [M + H–C4H8]+, [M + H–C5H8]+, [M + H–C6H6O]+, [M + H–C7H10O2]+, and [M + H–C8H8O]+, respectively. The compound was putatively characterized as licochalcone A. Chalcones like echinatin and licochalcone A undergo Nazarov cyclization with loss of a ketene (C2H2O, 42 Da).
The identification of glabridin was taking as the example of isoflavans for illustration. Compound 561 with a retention time of 25.69 min exhibited the precursor ion of [M − H]- at m/z 323.12963, corresponding to a molecular formula of C20H20O4. In the MS2 spectrum, the fragments at m/z 305.11823, m/z 281.11824, m/z 279.13909, m/z 253.12331, m/z 213.09199, m/z 201.09201, m/z 187.07632, m/z 175.07638, m/z 147.0451, and m/z 135.04509 corresponded to [M-H-H2O]-, [M-H-C2H2O]-, [M-H-CO2]-, [M-H-C3H2O2]-, [M-H-C6H6O2]-, [M-H-C7H6O2]-, [M-H-C8H8O2]-, [M-H-C9H8O2]-, [M-H-C11H12O2]-, and [M-H-C12H12O2]-. It was putatively characterized as glabridin.
3.1.2. Phenylpropanoids
Phenylpropanoids, for example, pinoresinol shows anti-inflammatory activity [32]. Compound 357 with a retention time of 13.53 min exhibited the precursor ion of [M − H]- at m/z 357.13430, corresponding to a molecular formula of C20H22O6. In the MS2 spectrum, peaks at m/z 342.11064, m/z 151.03982, and m/z 136.01635 corresponded to [M-H-CH3]-, [M-H-C12H14O3]-, and [M-H–CH3–C12H14O3]-, respectively. Thus it could be temporarily deduced as pinoresinol. Compound 148 with a retention time of 6.71 min exhibited the precursor ion of [M − H]- at m/z 681.23921, corresponding to a molecular formula of C32H42O16. In the MS2 spectrum, peaks at m/z 519.18676 and m/z 357.13420 corresponded to [M-H-Glc]- and [M-H-2Glc]-. Thus it was putatively characterized as pinoresinol diglucoside.
Compound 437 with a retention time of 18.04 min exhibited the precursor ion of [M+H]+ at m/z 373.16478, corresponding to a molecular formula of C21H24O6. In the MS2 spectrum, peaks at m/z 355.15517, m/z 337.14392, m/z 305.11683, m/z 284.10392, and m/z 269.08038 corresponded to [M + H–H2O]+, [M + H–2H2O]+, [M + H–CH8O3]+, [M + H–C4H9O2]+, and [M + H–C5H12O2]+, respectively. The fragment ion m/z 306.12496 was also observed. Thus it could be temporarily deduced as phillygenin. Compound 517 with a retention time of 22.64 min exhibited the precursor ion of [M+H]+ at m/z 369.13218, corresponding to a molecular formula of C21H20O6. In the MS2 spectrum, peaks at m/z 313.06983 and m/z 285.07497, corresponded to [M + H–C4H8]+ and [M + H–C4H8–CO]+, respectively. Thus it could be temporarily deduced as glycycoumarin. And the MS/MS spectrum is shown in Fig. 4. Compound 558 with a retention time of 25.27 min exhibited the precursor ion of [M+H]+ at m/z 367.11745, corresponding to a molecular formula of C21H18O6. In the MS2 spectrum, peaks at m/z 339.12218, m/z 311.05439, m/z 296.03083, and m/z 283.05943, corresponded to [M + H–CO]+, [M + H–C4H8]+, [M + H–C4H8–CH3]+, and [M + H–C4H8–CO]+, respectively. Thus it could be temporarily deduced as neoglycyrol.
Fig. 4.
The MS/MS spectrum of glycycoumarin.
3.1.3. Phenylethanoid glycosides
Phenylethanoid glycosides, for example, forsythoside B shows protective effect against lipopolysaccharide-induced acute lung injury [33]. The chemical structures of forsythoside A, forsythoside H, forsythoside I and acteoside all consist of four chemical moieties: caffeoyl, hydroxytyrosol, Rha and Glc. Compound 201 with a retention time of 7.87 min exhibited the precursor ion of [M − H]- at m/z 623.19775, corresponding to a molecular formula of C29H36O15. In the MS2 spectrum, peaks at m/z 477.13982, m/z 461.16604, m/z 443.15545, m/z 315.10830, m/z 297.09774, m/z 179.03475, m/z 161.02417, m/z 135.04491, m/z 133.02926 corresponded to [M-H-C6H10O4]-, [M-H-C9H6O3]-, [M-H–C9H6O3–H2O]-, [M-H–C6H10O4–C9H6O3]-, [M-H–C9H6O3–H2O–C6H10O4]-, [M-H–C6H10O4–C6H10O5–C8H8O2]-, [M-H–C6H10O4–C6H10O5–C8H8O2–H2O]-, [M-H–C6H10O4–C6H10O5–C8H8O2–CO2]-, and [M-H–C6H10O4–C6H10O5–C8H8O2–CH2O2]-, respectively. Fragment ions m/z 477.13982 and m/z 315.10830 corresponded to successive losses of Rha and caffeoyl groups. Fragment ions m/z 461.16604, m/z 443.15545, and m/z 297.09774 corresponded to successive losses of caffeoyl, H2O, and Rha groups. Fragment ion m/z 179.03475 corresponded to losses of Rha, Glc, and hydroxytyrosol groups, also can be [M − H]- of caffeic acid, then the eliminations of H2O, CO2 and CH2O2 from the fragment ion m/z 179.03475, respectively, resulting in producting the fragment ions m/z 161.02417, m/z 135.04491, and m/z 133.02926, respectively. The compound was confirmed as forsythoside I. Compound 192 (tR = 7.64 min), compound 235 (tR = 8.66 min) and compound 239 (tR = 8.82 min) showed deprotonated ions [M − H]- at m/z 623.19692, m/z 623.19737 and m/z 623.19642, with similar fragment behaviors to that of forsythoside I. They were putatively characterized as forsythoside H, forsythoside A, and acteoside, respectively. The chemical structures of forsythoside B consist of five chemical moieties: caffeoyl, hydroxytyrosol, Api, Rha and Glc. Compound 191 with a retention time of 7.56 min exhibited the precursor ion of [M − H]- at m/z 755.23923, corresponding to a molecular formula of C34H44O19. In the MS2 spectrum, peaks at m/z 593.20777, m/z 461.16525, m/z 447.14973, and m/z 161.02423 corresponded to [M-H-C9H6O3]-, [M-H–C9H6O3–C5H8O4]-, [M-H–C9H6O3–C6H10O4]-, and [M-H–C6H10O4–C5H8O4–C6H10O5–C8H8O2–H2O]-, respectively. Fragment ions m/z 593.20777 corresponded to loss of caffeoyl group, then the ion further fragmented into two ions at m/z 461.16525 and m/z 447.14973, owing to losses of Api and Rha groups, respectively. Fragment ion m/z 161.02423 corresponded to successive losses of caffeoyl, Api, Rha, Glc, hydroxytyrosol and H2O. The compound could be temporarily deduced as forsythoside B. And the MS/MS spectrum is shown in Fig. 5.
Fig. 5.
The MS/MS spectrum of forsythoside B.
3.1.4. Terpenoids
Terpenoids, for example, glycyrrhizic acid could ameliorate acute lung injury [34]. Compound 463 with a retention time of 19.49 min exhibited the precursor ion of [M+H]+ at m/z 823.41127, indicating the molecular formula of C42H62O16. In positive mode, the consequently losses of one and two glucuronic acid produced the fragment ions at m/z 647.37690 and m/z 471.34606. Fragment ion at m/z 453.33547 was corresponded with the losses of diglucuronic acid and H2O. Fragment ion in negative mode at m/z 351.05688 was corresponded with the diglucuronic acid. It was identified as glycyrrhizic acid. Compound 586 with a retention time of 28.79 min exhibited the precursor ion of [M+H]+ at m/z 471.34712, indicating the molecular formula of C30H46O4. Peaks at m/z 453.33496, m/z 435.32485, m/z 425.34051, m/z 407.32982, and m/z 389.31953 can be attributed to [M + H–H2O]+, [M + H–2H2O]+, [M + H–H2O–CO]+, [M + H–2H2O–CO]+, and [M + H–3H2O–CO]+, respectively. It was identified as glycyrrhetinic acid.
Compound 138 with a retention time of 6.50 min exhibited the precursor ion of [M+H]+ at m/z 359.13412, corresponding to a molecular formula of C16H22O9. In the MS2 spectrum, the characteristic fragment ions were at m/z 197.08054, m/z 179.06999, and m/z 127.03880 corresponded to [M + H-Glc]+, [M + H-Glc-H2O]+, and [M + H-Glc-C4H6O]+, respectively. The product ion at m/z 127.03880 is generated from the precursor ion through RDA cleavage. The compound was putatively characterized as sweroside. Compound 289 with a retention time of 10.66 min exhibited the precursor ion of [M − H]- at m/z 539.17665, corresponding to a molecular formula of C25H32O13. In the MS2 spectrum, peaks at m/z 377.12411, m/z 345.09810, m/z 327.08791, m/z 307.08229, and m/z 275.09239 corresponded to [M-H-Glc]-, [M-H-Glc-CH3OH]-, [M-H-Glc–CH3OH–H2O]-, [M-H-Glc-C4H6O]-, and [M-H-Glc-C4H6O3]-, respectively. Thus it was tentatively characterized as oleuropein. Compound 334 with a retention time of 12.65 min exhibited the precursor ion of [M − H]- at m/z 504.18704, corresponding to a molecular formula of C25H31NO10. In the MS2 spectrum, peaks at m/z 342.13431, m/z 324.12389, m/z 314.13969, and m/z 272.09264 corresponded to [M-H-Glc]-, [M-H-Glc-H2O]-, [M-H-Glc-CO]-, and [M-H-Glc-C4H6O]-, respectively. Thus it was confirmed as L-phenylalaninosecologanin B. And the MS/MS spectrum is shown in Fig. 6.
Fig. 6.
The MS/MS spectrum of L-phenylalaninosecologanin B.
3.1.5. Organic acids and their derivatives
A total of 79 organic acids and their derivatives were identified in this study. Organic acid compounds, for example, azelaic acid possesses anti-infective and anti-inflammatory activities [35]. Compound 15 with a retention time of 1.78 min exhibited the precursor ion of [M − H]- at m/z 169.01406, corresponding to a molecular formula of C7H6O5. In the MS2 spectrum, the characteristic fragments at m/z 125.02437 corresponded to [M-H-CO2]-. It was putatively characterized as gallic acid. Compound 186 with a retention time of 7.51 min exhibited the precursor ion of [M − H]- at m/z 197.04536, corresponding to a molecular formula of C9H10O5. In the MS2 spectrum, the characteristic fragments at m/z 169.01417 and m/z 125.02437 corresponded to [M-H-C2H4]- and [M-H-CO2]-. It was tentatively characterized as ethyl gallate. Compound 18 with a retention time of 1.90 min exhibited the precursor ion of [M − H]- at m/z 167.03481, corresponding to a molecular formula of C8H8O4. In the MS2 spectrum, the characteristic fragments at m/z 152.01129 and m/z 123.04502 corresponded to [M-H-CH3]- and [M-H-CO2]-. It was putatively characterized as vanillic acid. Compound 261 with a retention time of 9.82 min exhibited the precursor ion of [M − H]- at m/z 187.09736, corresponding to a molecular formula of C9H16O4. In the MS2 spectrum, the characteristic fragments at m/z 125.09712 corresponded to [M-H–CO2–H2O]-. It was putatively characterized as azelaic acid. Compound 351 with a retention time of 13.33 min exhibited the precursor ion of [M − H]- at m/z 207.06611, corresponding to a molecular formula of C11H12O4. In the MS2 spectrum, the characteristic fragments at m/z 179.03486, m/z 161.02430, and m/z 135.04505 corresponded to [M-H-C2H4]-, [M-H–C2H4–H2O]-, and [M-H–C2H4–CO2]-. It was putatively characterized as ethyl caffeate. And the MS/MS spectrum is shown in Fig. 7.
Fig. 7.
The MS/MS spectrum of ethyl caffeate.
3.1.6. Quinones
Quinones, for example, emodin could alleviate pulmonary inflammation in rats with LPS-induced acute lung injury [36]. Compound 455 (tR = 18.88 min), and compound 556 (tR = 25.08 min) were isomers, which showed deprotonated ion [M − H]- at m/z 269.04540, and m/z 269.04543. The molecular formula was speculated to be C15H10O5. In the MS2 spectrum, the characteristic fragment ions of compound 455 produced were at m/z 240.04263, m/z 223.03987, and m/z 211.03980, respectively, corresponding to fragment ions [M-H-CHO]-, [M-H–CO–H2O]-, and [M-H-2CHO]-, respectively. The characteristic fragment ions of compound 556 produced were at m/z 241.05072, m/z 225.05569, and m/z 210.03224 respectively, corresponding to fragment ions [M-H-CO]-, [M-H-CO2]-, and [M-H–CO2–CH3]-, respectively. Compound 455 and compound 556 were tentatively characterized as aloe-emodin and emodin, respectively. And the MS/MS spectrum of compound 556 is shown in Fig. 8.
Fig. 8.
The MS/MS spectrum of emodin.
Compound 473 and peak 582 with a retention time of 19.91 min and 28.40 min yielded the precursor ion of [M − H]- at m/z 283.02465 and m/z 283.06098, respectively, corresponding to a molecular formula of C15H8O6 and C16H12O5. In the MS2 spectrum, compound 473 showed characteristic fragment ions at m/z 255.02976, m/z 239.03481, m/z 211.03994, and m/z 183.04508 corresponded to [M-H-CO]-, [M-H-CO2]-, [M-H–CO2–CO]-, and [M-H–CO2–2CO]-, respectively. Compound 582 showed characteristic fragment ions at m/z 269.04532, m/z 268.03751, and m/z 240.04258 corresponded to [M-H-CH2]-, [M-H-CH3]-, and [M-H–CH3–CO]-, respectively. Thus they could be temporarily deduced as rhein and physcion, respectively.
Compound 572 with a retention time of 27.41 min exhibited the precursor ion of [M − H]- at m/z 253.05052, corresponding to a molecular formula of C15H10O4. Peaks at m/z 225.05551, m/z 210.03201, m/z 197.06060, m/z 182.03707, and m/z 181.06569 can be attributed to [M-H-CO]-, [M-H–CO–CH3]-, [M-H-2CO]-, [M-H-2CO–CH3]-, and [M-H–CO–CO2]-, respectively. It was confirmed as chrysophanol.
3.1.7. Alkaloids
Alkaloids, for example, norisoboldine could attenuate sepsis-induced acute lung injury [37]. Compound 43 was found at 3.15 min and exhibited an [M+H]+ ion at m/z 166.12289 with a molecular formula of C10H15NO. Peak at m/z 148.11149 corresponded to [M-H-H2O]+. It was tentatively confirmed as ephedrine or pseudoephedrine. Compound 65 was found at 4.14 min and exhibited an [M+H]+ ion at m/z 180.13858 with a molecular formula of C11H17NO. Peak at m/z 162.12735 corresponded to [M-H-H2O]+. It was tentatively confirmed as methylephedrine or methylpseudoephedrine. Compound 118 was found at 6.13 min and exhibited an [M+H]+ ion at m/z 314.13928 with a molecular formula of C18H19NO4. Peaks at m/z 297.11136, m/z 265.08524, and m/z 237.09039 corresponded to [M + H–NH3]+, [M + H–NH3–CH3OH]+, and [M + H–NH3–CH3OH–CO]+, respectively. It was identified as norisoboldine. And the MS/MS spectrum is shown in Fig. 9. Compound 465 was found at 19.61 min and exhibited an [M+H]+ ion at m/z 322.10739 with a molecular formula of C19H15NO4. Peak at m/z 292.05967 corresponded to [M + H–2CH3]+. It was tentatively characterized as cepharadione B. Compound 548 was found at 24.68 min and exhibited an [M+H]+ ion at m/z 445.21207 with a molecular formula of C27H28N2O4. Peaks at m/z 224.10647 and m/z 194.11695 corresponded to [M + H–C12H14NO3]+ and [M + H–C16H12NO2]+. It was tentatively characterized as aurantiamide acetate.
Fig. 9.
The MS/MS spectrum of norisoboldine.
3.1.8. Alcohol glycosides
Alcohol glycosides, for example, rosavin could show protective effects on bleomycin-induced pulmonary fibrosis [38]. Compound 229 was found at 8.39 min and exhibited an [M + COOH]- ion at m/z 473.16680 with an elemental composition of C20H28O10. Peaks at m/z 427.16049, m/z 293.08757, m/z 233.06640, m/z 191.05601, m/z 149.04540, and m/z 131.03490, corresponded to [M − H]-, [M-H-C9H10O]-, [M-H-C11H14O3]-, [M-H-C13H16O4]-, [M-H-C15H18O5]-, and [M-H-C15H20O6]- fragments, respectively. Compound 229 was confirmed as rosavin. And the MS/MS spectrum is shown in Fig. 10. Compound 347 was found at 13.14 min and exhibited an [M − H]- ion at m/z 493.22872 with an elemental composition of C22H38O12. Peak at m/z 447.22333 corresponded to [M-H-CH2O2]-. Compound 347 was confirmed as rhodioloside C.
Fig. 10.
The MS/MS spectrum of rosavin.
3.1.9. Others
For example, amygdalin has anti-inflammatory and immunomodulatory properties [39]. The precursor ion [M − H]- of compound 112 at m/z 456.15077 was observed at 5.96 min, the molecular formula was C20H27NO11 as predicted by the precursor ion. The characteristic fragment ion found in the MS/MS spectra was at m/z 323.09813 corresponded to [M-H-C8H7NO]-. The compound was tentatively characterized as amygdalin. The precursor ion [M − H]- of compound 317 at m/z 819.28569 was observed at 11.83 min, the molecular formula was C43H48O16 as predicted by the precursor ion. The characteristic fragment ion found in the MS/MS spectra was at m/z 611.21282 and m/z 403.13946, corresponded to [M-H-C11H12O4]- and [M-H-2C11H12O4]-. The compound was tentatively characterized as dryocrassin ABBA. And the MS/MS spectrum is shown in Fig. 11. The precursor ion [M − H]- of compound 565 at m/z 223.09741 was observed at 26.40 min, the molecular formula was C12H16O4 as predicted by the precursor ion. The characteristic fragment ion found in the MS/MS spectra was at m/z 139.07642 corresponded to [M-H-C4H4O2]-. The compound was tentatively characterized as pogostone.
Fig. 11.
The MS/MS spectrum of dryocrassin ABBA.
This study applied UHPLC-FT-ICR-MS/MS method to identify the chemical components in Lianhua Qingwen capsule, indirectly indicating that UHPLC-FT-ICR-MS/MS method can be efficient, accurate, and sensitive analysis of Lianhua Qingwen capsule chemical profile. According to the above analysis results, 596 compounds in Lianhua Qingwen capsule were identified, mostly have anti-inflammatory, antioxidant, antiviral, antibacterial, and other biological activities, and many studies have reported that they are closely related to the treatment of lung diseases, which correspond with the therapeutic indications.
4. Conclusion
In this study, a rapid, sensitive and accurate UHPLC-FT-ICR-MS/MS method was applied for the global profiling of the Lianhua Qingwen capsule, wherein 596 components were appropriately separated and characterized due to the accurate mass fragments and retention time. The profiles of the constituents in the Lianhua Qingwen capsule provided comprehensive chemical information, thereby providing a theoretical foundation for consecutive research on the effective components, its quality control, pharmacology research, and the promotion of future development of the Lianhua Qingwen capsule.
Funding
This study was supported by the National Natural Science Foundation of China (82003935), Natural Science Foundation of Liaoning Province (2023-MS-326), Basic Scientific Research Project of Education Department of Liaoning Province (LJKQZ20222409), and Startup Foundation for Doctors of Shenyang Medical College (20195077).
Data availability statement
The data are contained within the article and supplementary materials.
CRediT authorship contribution statement
Ting Liu: Writing – review & editing, Writing – original draft, Visualization, Supervision, Project administration, Investigation, Funding acquisition, Formal analysis, Conceptualization. Shu Lin: Writing – review & editing.
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Footnotes
Supplementary data to this article can be found online at https://doi.org/10.1016/j.heliyon.2024.e27352.
Appendix A. Supplementary data
The following is/are the supplementary data to this article.
References
- 1.Wang C.H., Zhong Y., Zhang Y., Liu J.P., Wang Y.F., Jia W.N., Wang G.C., Li Z., Zhu Y., Gao X.M. A network analysis of the Chinese medicine Lianhua-Qingwen formula to identify its main effective components. Mol. Omics. 2016;12(2):606–613. doi: 10.1039/c5mb00448a. [DOI] [PubMed] [Google Scholar]
- 2.Yang C., Wang Y., He J., Yan W., Jiang H., Chen Q., Li L., Yang Z. Lianhua-Qingwen displays antiviral and anti-Inflammatory activity and synergistic effects with Oseltamivir against influenza B virus infection in the mouse model. Evid. Based Complement Alternat. Med. 2020;2020 doi: 10.1155/2020/3196375. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]
- 3.Ding Y.W., Zeng L.J., Li R.F., Chen Q.Y., Zhou B.X., Chen Q.L., Cheng P.L., Yutao W., Zheng J.P., Yang Z.F., Zhang F.X. The Chinese prescription lianhuaqingwen capsule exerts anti-influenza activity through the inhibition of viral propagation and impacts immune function. BMC Compl. Alternative Med. 2017;17(1):130. doi: 10.1186/s12906-017-1585-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Duan Z.P., Jia Z.H., Zhang J., Liu S., Chen Y., Liang L.C., Zhang C.Q., Zhang Z., Sun Y., Zhang S.Q., Wang Y.Y., Wu Y.L. Natural herbal medicine Lianhuaqingwen capsule anti-influenza A (H1N1) trial: a randomized, double blind, positive controlled clinical trial. Chin. Med. J. 2011;124:2925–2933. [PubMed] [Google Scholar]
- 5.Li R.F., Hou Y.L., Huang J.C., Pan W.Q., Ma Q.H., Shi Y.X., Li C.F., Zhao J., Jia Z.H., Jiang H.M., Zheng K., Huang S.X., Dai J., Li X.B., Hou X.T., Wang L., Zhong N.S., Yang Z.F. Lianhuaqingwen exerts anti-viral and anti-inflammatory activity against novel coronavirus (SARS-CoV-2) Pharmacol. Res. 2020;156 doi: 10.1016/j.phrs.2020.104761. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Liang C.Y., Hui N., Liu Y., Qiao G.P., Li J., Tian L., Ju X.K., Jia M.Y., Liu H., Cao W.Q., Yu P., Li H., Ren X.D. Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: a Chinese herbal medicine repurposed for COVID-19 pandemic. Phytomed. Plus. 2021;1(2) doi: 10.1016/j.phyplu.2021.100027. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Gong X.W., Yuan B.Y., Yuan Y.D., Li F.J. Efficacy and safety of lianhuaqingwen capsules for the prevention of coronavirus disease 2019: a Prospective open-Label controlled trial. Evid. Based Complement. Alternat. Med. 2021 doi: 10.1155/2021/7962630. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Shen P., Li J., Tu S.H., Wu Y.R., Peng Y.T., Chen G., Chen C. Positive effects of Lianhuaqingwen granules in COVID-19 patients: a retrospective study of 248 cases. J. Ethnopharmacol. 2021;278 doi: 10.1016/j.jep.2021.114220. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Liu M., Gao Y., Yuan Y., Yang K.L., Shi S.Z., Tian J.H., Zhang J.H. Efficacy and safety of herbal medicine (Lianhuaqingwen) for treating COVID-19: a systematic review and meta-analysis. Integr. Med. Res. 2021;10(1) doi: 10.1016/j.imr.2020.100644. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Jia W.N., Wang C.H., Wang Y.F., Pan G.X., Jiang M.M., Li Z., Zhu Y. Qualitative and quantitative analysis of the major constituents in Chinese medical preparation lianhua-qingwen capsule by UPLC-DAD-QTOF-MS. Sci. World J. 2015;2015:731–765. doi: 10.1155/2015/731765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Fu S., Cheng R.R., Deng Z.X., Liu T.G. Qualitative analysis of chemical components in Lianhua Qingwen capsule by HPLC-Q Exactive-Orbitrap-MS coupled with GC-MS. J Pharm Anal. 2021;11(6):709–716. doi: 10.1016/j.jpha.2021.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Chen X.F., Wu Y.L., Chen C., Gu Y.Q., Zhu C.Y., Wang S.P., Chen J.Y., Zhang L., Lv L., Zhang G.Q., Yuan Y.F., Chai Y.F., Zhu M.S., Wu C.S. Identifying potential anti-COVID-19 pharmacological components of traditional Chinese medicine Lianhuaqingwen capsule based on human exposure and ACE2 biochromatography screening. Acta Pharm. Sin. B. 2021;11(1):222–236. doi: 10.1016/j.apsb.2020.10.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Smith D.F., Kiss A., Leach F.E., III, Robinson E.W., Paša-Tolić L., Heeren R.M. High mass accuracy and high mass resolving power FT-ICR secondary ion mass spectrometry for biological tissue imaging. Anal. Bioanal. Chem. 2013;405:6069–6076. doi: 10.1007/s00216-013-7048-1. [DOI] [PubMed] [Google Scholar]
- 14.Nikolaev E.N., Kostyukevich Y.I., Vladimirov G.N. Fourier transform ion cyclotron resonance (FT ICR) mass spectrometry: Theory and simulations. Mass Spectrom. Rev. 2016;35(2):219–258. doi: 10.1002/mas.21422. [DOI] [PubMed] [Google Scholar]
- 15.Frahm J.L., Howard B.E., Heber S., Muddiman D.C. Accessible proteomics space and its implications for peak capacity for zero-, one- and two-dimensional separations coupled with FT-ICR and TOF mass spectrometry. J. Mass Spectrom. 2006;41(3):281–288. doi: 10.1002/jms.1024. [DOI] [PubMed] [Google Scholar]
- 16.Kim D., Kim S., Son S., Jung M.J., Kim S. Application of online liquid chromatography 7 T FT-ICR mass spectrometer Equipped with Quadrupolar detection for analysis of Natural organic Matter. Anal. Chem. 2019;91(12):7690–7697. doi: 10.1021/acs.analchem.9b00689. [DOI] [PubMed] [Google Scholar]
- 17.Kruppa G., Schnier P.D., Tabei K., Van Orden S., Siegel M.M. Multiple ion isolation applications in FT-ICR MS: exact-mass MSn internal calibration and purification/interrogation of protein-drug complexes. Anal. Chem. 2002;74(15):3877–3886. doi: 10.1021/ac020048q. [DOI] [PubMed] [Google Scholar]
- 18.Liu T., Cui Y., Tian X.M., Li S.H., Han F., Ji B., Zhao Y.L., Yu Z.G. Detection of chemical constituents in Gegenqinlian decoction by ultra-high performance liquid chromatography coupled with Fourier transform ion cyclotron resonance mass spectrometry. Anal. Methods. 2017;9(40):5890–5902. [Google Scholar]
- 19.Han F., Li Y.T., Ma L., Liu T.F., Wu Y.W., Xu R., Song A.H., Yin R. A rapid and sensitive UHPLC-FT-ICR MS/MS method for identification of chemical constituents in Rhodiola crenulata extract, rat plasma and rat brain after oral administration. Talanta. 2016;160:183–193. doi: 10.1016/j.talanta.2016.07.014. [DOI] [PubMed] [Google Scholar]
- 20.Guan Z.B., Wang M., Cai Y., Yang H.M., Zhao M., Zhao C.J. Rapid characterization of the chemical constituents of Sijunzi decoction by UHPLC coupled with Fourier transform ion cyclotron resonance mass spectrometry. J. Chromatogr., B: Anal. Technol. Biomed. Life Sci. 2018;1086:11–22. doi: 10.1016/j.jchromb.2018.04.009. [DOI] [PubMed] [Google Scholar]
- 21.Cui Y., Yang H.H., Jing J.X., Liu T., Wang R.J., Di F.Y., Han F., Zhao Y.L., Yu Z.G. Rapid characterization of chemical constituents of Gansuibanxia decoction by UHPLC-FT-ICR-MS analysis. J. Pharm. Biomed. Anal. 2020;179 doi: 10.1016/j.jpba.2019.113029. [DOI] [PubMed] [Google Scholar]
- 22.Liu J.N., Zhao M., Zhang S., Liu J.N., Zhao C.J., Wang M. Rapid characterization of the chemical constituents of Wangbi Capsule by UPLC coupled with Fourier transform ion cyclotron resonance mass spectrometry. Microchem. J. 2022;180 [Google Scholar]
- 23.Wang C.C., Cai Z.C., Shi J.J., Chen S.Y., Tan M.X., Chen J.L., Chen L.H., Zou L.S., Chen C.H., Liu Z.X., Liu X.H. Comparative metabolite profiling of wild and cultivated licorice based on ultra-fast liquid chromatography coupled with triple quadrupole-time of flight tandem mass spectrometry. Chem. Pharm. Bull (Tokyo) 2019;67(10):1104–1115. doi: 10.1248/cpb.c19-00423. [DOI] [PubMed] [Google Scholar]
- 24.Li R.Y., Zhu Y.R., Ma M.Y., Lei M., Zhao Y.C., Liu T., Yu M., Zhao Y.L., Yu Z.G. Characterization of chemical constituents in Shuanghuanglian oral dosage forms by ultra-high performance liquid chromatography coupled with time-of-flight mass spectrometry. J. Separ. Sci. 2022;45(5):1020–1030. doi: 10.1002/jssc.202100860. [DOI] [PubMed] [Google Scholar]
- 25.Chen L., Yao C.L., Li J.Y., Wang J., Yao S., Shen S.J., Yang L., Zhang J.Q., Wei W.L., Bi Q.R., Guo D.A. Systematic characterization of chemical constituents in Mahuang decoction by UHPLC tandem linear ion trap-Orbitrap mass spectrometry coupled with feature-based molecular networking. J. Separ. Sci. 2021;44(14):2717–2727. doi: 10.1002/jssc.202100121. [DOI] [PubMed] [Google Scholar]
- 26.Jiang X.J., Lin Y.H., Wu Y.L., Yuan C.X., Lang X.L., Chen J.Y., Zhu C.Y., Yang X.Y., Huang Y., Wang H., Wu C.S. Identification of potential anti-pneumonia pharmacological components of Glycyrrhizae Radix et Rhizoma after the treatment with Gan an He Ji oral liquid. J. Pharm. Anal. 2022;12(6):839–851. doi: 10.1016/j.jpha.2022.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Xu S.Y., Xu X.F., Yuan S.X., Liu H., Liu M.N., Zhang Y., Zhang H., Gao Y., Lin R.C., Li X.R. Identification and analysis of amygdalin, neoamygdalin and amygdalin amide in different processed bitter almonds by HPLC-ESI-MS/MS and HPLC-DAD. Molecules. 2017;22(9):1425. doi: 10.3390/molecules22091425. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Tao W.W., Duan J.A., Guo J.M., Li J.P., Tang Y.P., Liu P., Yang N.Y. Simultaneous determination of triterpenoid saponins in dog plasma by a validated UPLC-MS/MS and its application to a pharmacokinetic study after administration of total saponin of licorice. J. Pharm. Biomed. Anal. 2013;75:248–255. doi: 10.1016/j.jpba.2012.11.035. [DOI] [PubMed] [Google Scholar]
- 29.Ding Y.M., Liu Z., Li F.Q. Application of a sensitive and accurate LC-MS/MS method for determination of dryocrassin ABBA in rat plasma for a bioavailability study. Biomed. Chromatogr. 2014;28(9):1205–1211. doi: 10.1002/bmc.3147. [DOI] [PubMed] [Google Scholar]
- 30.Li Y.C., Su Z.R., Lin S.H., Li C.W., Zhao Y., Gao X., Lai Y.Q., Wu X.L., Wu H.Z., Cai Z.W. Characterisation of the metabolism of pogostone in vitro and in vivo using liquid chromatography with mass spectrometry. Phytochem. Anal. 2014;25(2):97–105. doi: 10.1002/pca.2471. [DOI] [PubMed] [Google Scholar]
- 31.Wang L., Wang X.H., Kong L.N., Wang S.Y., Huang K., Wu J.J., Wang C.Y., Sun H.J., Liu K.X., Meng Q. Isoliquiritigenin alleviates LPS/D-GalN-induced acute liver failure by activating the PGC-1α/Nrf2 pathway to reduce oxidative stress and inflammatory response. Int. Immunopharm. 2021;100 doi: 10.1016/j.intimp.2021.108159. [DOI] [PubMed] [Google Scholar]
- 32.Jung H.W., Mahesh R., Lee J.G., Lee S.H., Kim Y.S., Park Y.K. Pinoresinol from the fruits of Forsythia koreana inhibits inflammatory responses in LPS-activated microglia. Neurosci. Lett. 2010;480(3):215–220. doi: 10.1016/j.neulet.2010.06.043. [DOI] [PubMed] [Google Scholar]
- 33.Liu J.X., Li X., Yan F.G., Pan Q.J., Yang C., Wu M.Y., Li G., Liu H.F. Protective effect of forsythoside B against lipopolysaccharide-induced acute lung injury by attenuating the TLR4/NF-κB pathway. Int. Immunopharm. 2019;66:336–346. doi: 10.1016/j.intimp.2018.11.033. [DOI] [PubMed] [Google Scholar]
- 34.Qu L.H., Chen C., He W., Chen Y.Y., Li Y., Wen Y., Zhou S.C., Jiang Y.Q., Yang X.P., Zhang R., Shen L. Glycyrrhizic acid ameliorates LPS-induced acute lung injury by regulating autophagy through the PI3K/AKT/mTOR pathway. Am. J. Transl. Res. 2019;11(4):2042–2055. [PMC free article] [PubMed] [Google Scholar]
- 35.Schulte B.C., Wu W., Rosen T. Azelaic acid: evidence-based update on mechanism of action and clinical application. J. Drugs Dermatol. JDD. 2015;14(9):964–968. [PubMed] [Google Scholar]
- 36.Li X.Q., Shan C., Wu Z.H., Yu H.J., Yang A.D., Tan B. Emodin alleviated pulmonary inflammation in rats with LPS-induced acute lung injury through inhibiting the mTOR/HIF-1α/VEGF signaling pathway. Inflamm. Res. 2020;69(4):365–373. doi: 10.1007/s00011-020-01331-3. [DOI] [PubMed] [Google Scholar]
- 37.Chen Q., Shao X.B., He Y.Y., Lu E.K., Zhu L.J., Tang W.D. Norisoboldine attenuates sepsis-induced acute lung injury by modulating macrophage polarization via PKM2/HIF-1α/PGC-1α pathway. Biol. Pharm. Bull. 2021;44(10):1536–1547. doi: 10.1248/bpb.b21-00457. [DOI] [PubMed] [Google Scholar]
- 38.Xin X.B., Yao D.H., Zhang K., Han S., Liu D.N., Wang H.Y., Liu X.Y., Li G.Y., Huang J., Wang J.H. Protective effects of Rosavin on bleomycin-induced pulmonary fibrosis via suppressing fibrotic and inflammatory signaling pathways in mice. Biomed. Pharmacother. 2019;115:108870. doi: 10.1016/j.biopha.2019.108870. [DOI] [PubMed] [Google Scholar]
- 39.He X.Y., Wu L.J., Wang W.X., Xie P.J., Chen Y.H., Wang F. Amygdalin-A pharmacological and toxicological review. J. Ethnopharmacol. 2020;254 doi: 10.1016/j.jep.2020.112717. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data are contained within the article and supplementary materials.











